Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

C3_BILIARY_GALLBLADDER_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C22, C23&, C24 Hospital discharge: ICD-9 — 155\|156 Hospital discharge: ICD-8 — 155\|156 Cause of death: ICD-10 — C22, C23&, C24 Cause of death: ICD-9 — 155\|156 Cause of death: ICD-8 — 155\|156 Cancer registry: Topography ICD-O-3 — C2[2-4] Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	2661
4. Check minimum number of events None	2661
5. Include endpoints C3_LIVER_INTRAHEPATIC_BILE_DUCTS_WIDE C3_GALLBLADDER_WIDE C3_BILIARY_TRACT_WIDE	2661
6. Filter based on genotype QC (FinnGen only)	2574

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_BILIARY_GALLBLADDER_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_LIVER_INTRAHEPATIC_BILE_DUCTS_WIDE\|C3_GALLBLADDER_WIDE\|C3_BILIARY_TRACT_WIDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C2[2-4]
HD_ICD_9	155\|156
HD_ICD_8	155\|156
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C2[2-4]
COD_ICD_9	155\|156
COD_ICD_8	155\|156
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C2[2-4]
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo based on the number of shared cases.

Similar with more cases:

Malignant neoplasm, wide definition for exclusion

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2574	859	1715
Unadjusted period prevalence (%)	0.63	0.30	0.79
Median age at first event (years)	71.80	71.07	72.17

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2661: Matched controls
26610

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R18

ICD-10 Finland

Ascites

19.1

322.7

260

150

JK3BT

NOMESCO Finland

Catherisation of bile duct with X-ray guidance

109.9

321.8

165

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

315.0

296

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

19.7

313.7

249

139

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

20.5

307.7

305

167

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

307.7

581

UJK02

NOMESCO Finland

ERCP

17.6

307.7

432

290

JN4BD

NOMESCO Finland

Extensive body CT

10.5

307.7

521

603

H02AB02

ATC

dexamethasone; systemic

61.0

307.7

595

125

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

5924.2

307.7

497

N02AA05

ATC

oxycodone; systemic

8.7

307.7

1227

2374

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

170.2

307.7

748

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

1250

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

20.5

307.7

257

138

A04AA01

ATC

ondansetron; systemic, rectal

22.5

307.7

402

209

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

12.3

307.7

358

332

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

32.7

307.7

326

113

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

+∞

307.7

562

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

24.8

307.7

248

110

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

10.2

307.7

742

973

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

31.9

307.7

316

112

A03FA01

ATC

metoclopramide; systemic, rectal

13.7

307.7

1175

1448

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

29.6

307.7

245

K83.1

ICD-10 Finland

Obstruction of bile duct

60.1

307.7

373

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

97.9

307.7

647

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

73.7

307.7

307

C24.9

ICD-10 Finland

Malignant neoplasm: Biliary tract, unspecified

+∞

307.7

310

JN4AD

NOMESCO Finland

Body CT examination

11.9

307.7

645

694

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

307.7

392

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

24.4

307.7

308

142

L01BC06

ATC

capecitabine; oral

+∞

307.7

364

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

16384.0

307.7

1079

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2172.8

307.7

396

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

20.9

307.7

260

137

WX302

NOMESCO Finland

Thoracal epidural anesthesy

23.3

307.7

404

203

JN4CD

NOMESCO Finland

Very extensive body CT

32.4

307.7

380

136

K83.0

ICD-10 Finland

Cholangitis

19.6

307.7

265

149

A04AA02

ATC

granisetron; systemic, transdermal

1097.6

307.7

456

Z51.5

ICD-10 Finland

Palliative care

28.3

307.7

987

543

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

25.9

305.4

215

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

16.5

289.6

251

167

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

16.4

281.7

245

164

WF002

NOMESCO Finland

Radical radiotherapy

87.0

280.7

148

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

7.6

275.0

430

660

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

5.1

264.4

678

1666

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

405.9

261.9

259

WZC00

NOMESCO Finland

Treatment plan or consultation

4.0

251.6

1108

4070

C23

ICD-10 Finland

Malignant neoplasm of gallbladder

+∞

248.9

235

JN3AD

NOMESCO Finland

Abdominal CT examination

5.2

241.4

581

1346

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

14.1

231.9

218

167

198

Kela drug reimbursment

Sorafenib

+∞

231.7

219

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

21.9

228.4

171

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

9.9

213.7

257

285

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

+∞

210.2

199

Z94.4

ICD-10 Finland

Liver transplant status

87.4

206.8

109

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

7.2

202.5

321

495

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

200.6

190

C61

ICD-10 Finland

Malignant neoplasm of prostate

424.4

199.9

198

JK3NB

NOMESCO Finland

Percutaneous transhepatic cholangiography

90.2

198.1

104

8160/3-C22.1

ICD-O-3

Cholangiocarcinoma of intrahepatic bile duct

+∞

197.4

187

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

81.5

191.7

102

JLC30

NOMESCO Finland

Pancreatoduodenectomy

502.8

190.9

188

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

38.7

186.9

115

L03AA02

ATC

filgrastim; parenteral

83.9

183.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

4.8

180.6

472

1155

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

180.3

171

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

38.8

175.6

108

A06AH03

ATC

naloxegol; oral

29.3

172.0

115

WZC30

NOMESCO Finland

Teaching

4.1

170.5

553

1592

XX3DW

NOMESCO Finland

Time consuming IT work

6.3

167.4

302

530

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

21.6

165.4

124

WW500

NOMESCO Finland

Blood transfusion

9.7

164.3

198

219

WF049

NOMESCO Finland

Radiotherapy of metastasis

1546.5

149.4

144

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

139.8

133

C24.1

ICD-10 Finland

Malignant neoplasm: Ampulla of Vater

+∞

138.8

132

A05AA02

ATC

ursodeoxycholic acid; oral

14.5

137.1

125

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

21.8

135.5

101

B01AB10

ATC

tinzaparin; parenteral

4.5

132.5

356

881

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

29.3

131.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.5

131.8

546

1833

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

131.3

125

L01XE05

ATC

[U] sorafenib

+∞

131.3

125

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1299.1

128.2

124

C24.0

ICD-10 Finland

Malignant neoplasm: Extrahepatic bile duct

+∞

125.0

119

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

119.8

1050

5292

C24.09

ICD-10 Finland

Biliary duct or passage NOS

+∞

118.6

113

L02AE02

ATC

leuprorelin; implant, parenteral

66.6

118.3

A04AA55

ATC

palonosetron, combinations; systemic

+∞

117.6

112

323

Kela drug reimbursment

Sorafenib

+∞

117.6

112

JAH01

NOMESCO Finland

Laparoscopy

7.7

117.3

169

232

D77

ICPC

Malignant digestive neopl other/NOS

598.7

117.0

115

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

24.4

116.6

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

+∞

116.5

111

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

35.7

116.2

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1167.7

115.6

112

127

Kela drug reimbursment

Transplant complication

14.3

115.6

106

TPH04

NOMESCO Finland

Cathetrisation of vein

2.8

115.3

767

3355

WX402

NOMESCO Finland

General anaesthesia

3.1

113.0

568

2128

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

560.5

109.6

108

116

Kela drug reimbursment

Prostate cancer

+∞

108.1

103

R50.9

ICD-10 Finland

Fever, unspecified

3.1

107.3

547

2061

8140/3-C23.9

ICD-O-3

Adenocarcinoma, NOS, of gallbladder

+∞

107.0

102

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

+∞

105.9

101

C03DA01

ATC

spironolactone; oral

2.9

104.0

606

2456

TPH07

NOMESCO Finland

Cathetrisation of artery

3.3

103.9

446

1516

R4190

NOMESCO Finland

Nutritional therapy

7.8

103.6

147

198

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

30.3

103.0

C24.00

ICD-10 Finland

Hepatic duct

+∞

101.7

UJK12

NOMESCO Finland

Peroral cholangioscopy

46.4

100.2

8160/3-C24.9

ICD-O-3

Cholangiocarcinoma of billiary tract, NOS

+∞

99.6

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

57.2

99.2

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

23.5

98.3

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

42.3

96.4

A07AA11

ATC

rifaximin; oral

34.7

96.2

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

95.4

B01AB05

ATC

enoxaparin; parenteral

2.4

94.6

934

4866

C24.02

ICD-10 Finland

Common bile duct

+∞

94.3

I81

ICD-10 Finland

Portal vein thrombosis

24.5

94.3

K76.9

ICD-10 Finland

Liver disease, unspecified

10.0

92.7

107

111

A06AD11

ATC

lactulose; oral

2.6

91.2

673

3056

8000/3-C80.9

ICD-O-3

Neoplasm, malignant of unknown primary site

+∞

91.2

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

22.5

89.9

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

34.2

89.6

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

16.7

89.3

TPX10

NOMESCO Finland

Implantation of vascular injection port

7.0

88.6

138

206

L04AD02

ATC

tacrolimus; systemic

16.4

88.4

N02AX02

ATC

tramadol; systemic, rectal

2.2

88.3

1300

7962

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

11.9

87.2

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

86.9

J01MA12

ATC

levofloxacin; systemic

2.6

86.9

667

3079

C24.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of biliary tract

+∞

85.9

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

85.9

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

85.9

JJC00

NOMESCO Finland

Allogenic transplantation of liver

117.7

84.5

8000/3-C24.9

ICD-O-3

Neoplasm, malignant of billiary tract, NOS

+∞

83.8

L03AA13

ATC

pegfilgrastim; parenteral

290.5

83.1

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

823.1

81.9

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.2

81.9

145

247

8140/3-C24.1

ICD-O-3

Adenocarcinoma, NOS, of ampulla of Vater

+∞

80.6

ZX120

NOMESCO Finland

Intravenous

3.5

80.6

299

920

A79

ICPC

Malignancy NOS

173.4

80.6

JAH00

NOMESCO Finland

Laparotomy

6.2

80.5

142

241

L01EX02

ATC

sorafenib; oral

+∞

78.5

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

77.5

JKA20

NOMESCO Finland

Cholecystectomy

5.1

75.6

165

341

L04AA06

ATC

mycophenolic acid; systemic

8.3

75.4

100

124

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

74.9

1371

8947

JK4ZT

NOMESCO Finland

Percutaneous transhepatic implantation of bile duct prothesis

377.7

74.1

D70.82

ICD-10 Finland

Drug-induced neutropenia

24.1

72.7

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

31.9

72.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.4

72.1

190

458

D13.4

ICD-10 Finland

Benign neoplasm: Liver

23.0

71.5

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

70.1

673

3394

B01AB04

ATC

dalteparin; parenteral

4.0

67.7

204

543

A02BC02

ATC

pantoprazole; systemic

2.1

67.1

1818

13471

3019

Kela drug reimbursment

Lenvatinib

+∞

67.0

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

14.2

66.5

JK3FT

NOMESCO Finland

Exchange of bile duct catheter with radiological guidance

174.4

65.3

C22.7

ICD-10 Finland

Malignant neoplasm: Other specified carcinomas of liver

+∞

64.8

1508

Kela drug reimbursment

Lenvatinib

+∞

64.8

115

Kela drug reimbursment

Breast cancer

+∞

63.8

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

101.2

63.1

L01EX08

ATC

lenvatinib; oral

+∞

62.7

ZXE30

NOMESCO Finland

More than five and less than seven hours

4.1

61.6

180

468

B18.2

ICD-10 Finland

Chronic viral hepatitis C

12.9

59.8

8160/3-C24.0

ICD-O-3

Cholangiocarcinoma of extrahepatic bile duct

+∞

59.6

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

59.6

HAB40

NOMESCO Finland

Wedge excision of mammary gland

20.8

59.3

A10AB05

ATC

insulin aspart; parenteral

2.9

59.2

316

1198

K75.0

ICD-10 Finland

Abscess of liver

23.0

59.0

A04AD12

ATC

aprepitant; systemic

+∞

58.5

D97

ICPC

Liver disease NOS

15.9

58.1

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

93.7

58.1

JJB30

NOMESCO Finland

Excision of two segments of liver

580.4

57.9

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

11.1

57.4

N02AA01

ATC

morphine; systemic, rectal

6.8

57.0

136

WF004

NOMESCO Finland

Palliative radiotherapy

570.0

56.8

PJA12

NOMESCO Finland

Sentinel node biopsy

292.9

56.4

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

56.1

994

6230

C03CA01

ATC

furosemide; systemic

1.9

55.4

1196

7993

WX004

NOMESCO Finland

Patient-controlled sedation

18.6

55.2

A10AE04

ATC

insulin glargine; parenteral

2.5

54.8

388

1692

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

70.4

54.3

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

11.0

54.0

R4110

NOMESCO Finland

Physiotherapy

2.0

53.4

746

4292

UJF32

NOMESCO Finland

Coloscopy

2.0

53.0

750

4332

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

10.4

52.1

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

6.9

51.9

121

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

517.8

51.6

8000/3-C22.1

ICD-O-3

Neoplasm, malignant of intrahepatic bile duct

+∞

51.2

8140/3-C24.0

ICD-O-3

Adenocarcinoma, NOS, of extrahepatic bile duct

+∞

50.2

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.2

49.7

478

2377

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.0

49.4

145

378

ZXE20

NOMESCO Finland

More than three and less than five hours

2.3

47.9

404

1899

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

4.9

47.9

108

229

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

47.0

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

47.0

JJB50

NOMESCO Finland

Excision of segments V, VI, VII and VIII of liver

166.3

47.0

PC2SC

NOMESCO Finland

Liver angiography with X-ray

465.7

46.4

176

Kela drug reimbursment

Regorafenib

+∞

46.0

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

46.0

ZXE40

NOMESCO Finland

More than seven and less than nine hours

5.1

45.9

198

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.9

45.7

881

5591

J01MA02

ATC

ciprofloxacin; systemic

1.8

44.2

1101

7533

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

8.9

44.1

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

228.8

44.1

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

5.1

43.6

184

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

42.2

427

2157

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

114.4

41.8

TJA10

NOMESCO Finland

Laparocentesis

114.4

41.8

K92.0

ICD-10 Finland

Haematemesis

3.8

41.8

129

348

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.0

41.5

558

3130

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

41.3

774

4842

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

413.9

41.2

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

413.9

41.2

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

40.7

C22

ICD-10 Finland

Malignant neoplasm of liver and intrahepatic bile ducts

+∞

40.7

8000/3-C24.0

ICD-O-3

Neoplasm, malignant of extrahepatic bile duct

+∞

40.7

L04AD01

ATC

ciclosporin; systemic

6.1

40.7

119

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

13.9

40.0

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

208.1

39.9

A10BA02

ATC

metformin; oral

1.8

39.8

959

6448

L02BB03

ATC

bicalutamide; oral

+∞

39.7

JK3NT

NOMESCO Finland

Percutaneous transhepatic dilatation of bileducts

53.1

39.6

JJA20

NOMESCO Finland

Open biopsy of liver

53.1

39.6

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

38.6

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

12.4

38.4

WF003

NOMESCO Finland

Adjuvant radiotherapy

197.8

37.9

KCD02

NOMESCO Finland

Transurethral resection of bladder

9.7

37.7

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

37.6

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

372.5

37.1

XX2RW, ,

NOMESCO Finland

12.6

36.7

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

36.5

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

35.5

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

35.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

35.2

830

5507

XJA00

NOMESCO Finland

Intraoperative abdominal ultrasonography

351.8

35.0

SPAT1109

SPAT

Analgesia with portable analgesic pump

12.7

34.9

Y77

ICPC

Malignant neoplasm prostate

96.4

34.8

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

7.1

34.8

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

4.8

34.7

165

369

Kela drug reimbursment

Regorafenib

+∞

34.4

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

34.4

8140/3-C24.9

ICD-O-3

Adenocarcinoma, NOS, of billiary tract, NOS

+∞

34.4

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

341.5

34.0

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

3.5

33.8

121

361

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

33.4

JJB71

NOMESCO Finland

Laparoscopic resection of liver

+∞

33.4

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

33.4

455

2546

T90

ICPC

Diabetes non-insulin dependent

1.7

33.3

749

4889

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

4.7

33.2

171

SPAT1262

SPAT

Handing over of treatment supplies

1.9

32.8

539

3205

WVA20

NOMESCO Finland

Medicine administration

4.3

32.6

207

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

32.4

ZX090

NOMESCO Finland

Other technic of radiotherapy

55.0

32.3

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

5.0

32.2

144

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

48.1

31.6

A41.8

ICD-10 Finland

Other specified sepsis

4.0

31.5

230

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

31.3

C17.0

ICD-10 Finland

Malignant neoplasm: Duodenum

+∞

31.3

ZX070

NOMESCO Finland

Intensity modified radiotherapy

111.4

30.7

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.8

30.7

146

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

+∞

30.3

JJB40

NOMESCO Finland

Excision of segments II, III and IV of liver

+∞

30.3

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

30.3

8000/3-C23.9

ICD-O-3

Neoplasm, malignant of gallbladder

+∞

30.3

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

+∞

30.3

L02BG04

ATC

letrozole; oral

33.0

30.0

WPB10

NOMESCO Finland

Making a convalescent care decision

41.6

29.9

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

10.4

29.8

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

156.8

29.7

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

4.0

29.7

222

C10AA07

ATC

rosuvastatin; oral

0.5

28.7

355

6077

WX002

NOMESCO Finland

Sedation and analgesia

1.8

28.6

512

3111

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.4

28.5

103

309

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.2

28.4

185

A10BB12

ATC

glimepiride; oral

2.1

28.3

308

1586

JJA44

NOMESCO Finland

Laparoscopic destruction of lesion of liver

+∞

28.2

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

28.2

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

28.2

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

64.7

28.0

A10BH01

ATC

sitagliptin; oral

2.0

27.8

328

1738

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

284.4

27.8

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

284.4

27.8

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

146.5

27.7

JFB30

NOMESCO Finland

Right hemicolectomy

8.3

27.4

L01EX05

ATC

regorafenib; oral

+∞

27.1

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

27.1

JKC30

NOMESCO Finland

Partial excision of bile duct and anastomosis to jejunum

+∞

27.1

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

27.1

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.6

27.1

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

9.5

27.1

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

8.4

27.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.7

27.0

147

559

WW200, ,

SPAT

0.4

27.0

184

3887

ZXC40

NOMESCO Finland

Use of ultrasound

10.8

26.9

ZZR00

NOMESCO Finland

Flap of skin

8.1

26.9

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.7

26.9

138

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

273.8

26.8

D76

ICPC

Malignant neoplasm pancreas

141.4

26.7

HA1AA

NOMESCO Finland

X-ray mammography

4.0

26.5

195

SPAT1255

SPAT

Intravenous administration of medicine

2.3

26.4

214

980

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

26.1

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

26.1

C24.01

ICD-10 Finland

Cystic duct

+∞

26.1

HAC20

NOMESCO Finland

Total mastectomy

94.4

25.7

K85.8

ICD-10 Finland

Other acute pancreatitis

7.1

25.4

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

25.2

136

515

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

+∞

25.0

ZXE00

NOMESCO Finland

One hour or less

1.6

24.8

875

6314

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.7

24.7

138

532

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

131.2

24.6

WX892

NOMESCO Finland

Monitored bed care

2.2

24.6

227

1096

NK6AN

NOMESCO Finland

Total body bone isotope imaging

24.6

24.4

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

24.0

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

24.0

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

24.0

299

1613

K72.1

ICD-10 Finland

Chronic hepatic failure

22.9

23.9

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

242.1

23.7

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

242.1

23.7

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

126.2

23.6

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.3

23.6

285

ZX050

NOMESCO Finland

Stereotactic radiotherapy

47.1

23.3

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

23.1

247

1261

1552X

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUMHEPATIS, NON DEFINITUM PRIM/SEC]

+∞

22.9

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

22.9

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

22.9

H01CB02

ATC

octreotide; parenteral

65.6

22.8

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

84.2

22.7

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

22.2

302

1676

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

22.1

168

3435

XQ902

NOMESCO Finland

Other photography

7.1

22.1

8140/3-C26.9

ICD-O-3

Adenocarcinoma, NOS, of gastrointestinal tract, NOS

+∞

21.9

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

21.9

JJ5AT, ,

NOMESCO Finland

63.1

21.9

JDE00

NOMESCO Finland

Gastrojejunostomy

80.8

21.7

A10AE05

ATC

insulin detemir; parenteral

2.3

21.4

175

804

A10BX07

ATC

[U] liraglutide

4.3

21.4

130

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.0

21.2

K72.9

ICD-10 Finland

Hepatic failure, unspecified

6.2

21.1

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

21.0

469

3007

L01XE21

ATC

[U] regorafenib

+∞

20.9

JJA43

NOMESCO Finland

Destruction of lesion of liver

+∞

20.9

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

20.9

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

20.9

TK800

NOMESCO Finland

Hemodialysis

3.4

20.8

225

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.8

20.8

105

384

ZX108

NOMESCO Finland

Inhalation

7.4

20.8

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

211.6

20.6

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

6.7

20.4

WX882

NOMESCO Finland

High dependency care

3.1

20.4

295

JN6AD

NOMESCO Finland

CT of torso and neck

7.0

20.4

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.8

20.3

100

361

XX4BW, ,

NOMESCO Finland

32.8

20.2

N05CF01

ATC

zopiclone; oral

1.5

20.1

833

6164

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.6

20.0

117

461

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

19.9

189

922

C10AX09

ATC

ezetimibe; oral

0.4

19.8

143

2991

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

19.8

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

19.8

B03XA02

ATC

darbepoetin alfa; parenteral

3.6

19.8

179

A98

ICPC

Health maint/preventive medicine

0.7

19.7

1869

20791

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

19.7

340

2028

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

19.6

191

940

K70.4

ICD-10 Finland

Alcoholic hepatic failure

7.4

19.5

N06DX01

ATC

memantine; oral

0.3

19.5

1977

RS220, ,

NOMESCO Finland

5.1

19.5

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

19.4

359

2184

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

19.3

278

1568

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

3.8

19.3

154

ZXD05

NOMESCO Finland

Urgent procedure

1.5

19.2

734

5329

JK3SB

NOMESCO Finland

Endoscopic retrorade cholangiography

20.2

19.0

160

Kela drug reimbursment

exenatide

3.2

18.9

229

C10AA05

ATC

atorvastatin; oral

0.7

18.8

719

9528

JJB20

NOMESCO Finland

Excision of single segment of liver

+∞

18.8

9680/3-C22.0

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of liver

+∞

18.8

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

18.8

1550A

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Liver, primary

+∞

18.8

Z2446

NOMESCO Finland

Social worker

2.3

18.7

148

671

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.2

18.6

153

704

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

21.0

18.6

ZX112

NOMESCO Finland

Subcutaneous

6.1

18.6

JJB60

NOMESCO Finland

Other excsion of three or more segments of liver

191.3

18.5

K92.1

ICD-10 Finland

Melaena

2.1

18.2

179

885

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

14.4

18.1

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.5

18.0

111

449

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

17.7

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

17.7

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

17.7

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

17.6

860

6539

A10AC01

ATC

insulin (human); parenteral

1.8

17.5

258

1465

C50.99

ICD-10 Finland

Breast, unspecified

181.2

17.5

C20

ICD-10 Finland

Malignant neoplasm of rectum

181.2

17.5

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.6

17.4

100

391

C10AC01

ATC

colestyramine; oral

3.1

17.4

241

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

5.4

17.3

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.7

17.3

352

L02BA01

ATC

tamoxifen; oral

42.3

17.3

C07AG02

ATC

carvedilol; oral

1.9

17.1

208

1109

N02AA03

ATC

hydromorphone; systemic, rectal

31.7

17.0

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.6

17.0

159

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.5

16.9

107

439

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

5.0

16.9

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

16.7

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

16.7

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

16.7

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

16.7

230

1279

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.9

16.6

124

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

16.4

16.5

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

20.2

16.4

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.8

16.2

295

K81.0

ICD-10 Finland

Acute cholecystitis

2.8

16.2

284

WPA43, ,

SPAT

47.8

16.0

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

47.8

16.0

K70.1

ICD-10 Finland

Alcoholic hepatitis

5.5

15.7

Z3226

NOMESCO Finland

Physiotherapist

1.6

15.7

411

2729

C22.4

ICD-10 Finland

Malignant neoplasm: Other sarcomas of liver

+∞

15.6

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

15.6

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

15.6

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

15.6

C22.3

ICD-10 Finland

Malignant neoplasm: Angiosarcoma of liver

+∞

15.6

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

15.6

P20

ICPC

Memory disturbance

0.5

15.6

181

3238

L04AA10

ATC

[U] sirolimus

85.6

15.6

X76

ICPC

Malignant neoplasm breast female

85.6

15.6

K51.5

ICD-10 Finland

Left sided colitis

3.0

15.6

230

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.1

15.5

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

160.9

15.5

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

160.9

15.5

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

160.9

15.5

Z51.0

ICD-10 Finland

Radiotherapy session

160.9

15.5

Z3231

NOMESCO Finland

Registered nurse

1.5

15.5

606

4393

WX704

NOMESCO Finland

Intubation

2.0

15.5

163

827

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

6.5

15.4

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

12.4

15.3

K76.89

ICD-10 Finland

Other specified diseases of liver

17.8

15.1

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

20.2

15.1

162

Kela drug reimbursment

liraglutide

3.8

14.8

116

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

57.0

14.8

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

14.6

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

14.6

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

14.6

PJD99

NOMESCO Finland

Excision of other lymph nodes

+∞

14.6

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

14.6

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

14.6

C80

ICD-10 Finland

Malignant neoplasm, without specification of site

+∞

14.6

WPA13

NOMESCO Finland

Palliative consultation

14.2

14.5

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

5.0

14.5

Z2221

NOMESCO Finland

Medical doctor

1.5

14.5

559

4033

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

4.6

14.5

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

4.2

14.4

J94.8

ICD-10 Finland

Other specified pleural conditions

3.3

14.4

162

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.3

14.3

105

461

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

14.0

118

549

G93.4

ICD-10 Finland

Encephalopathy, unspecified

6.7

14.0

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.1

14.0

133

649

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.0

14.0

201

D75

ICPC

Malignant neoplasm colon/rectum

30.2

13.9

R11

ICD-10 Finland

Nausea and vomiting

1.9

13.9

190

1054

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.6

13.8

SPAT1269

SPAT

Other puncture and/or drainage

6.3

13.7

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

13.6

212

1225

H02AB06

ATC

prednisolone; systemic

1.4

13.6

1106

9093

JJB53

NOMESCO Finland

Excision of segments IV,V, VI, VII and VIII of liver

+∞

13.5

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

13.5

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

13.5

C22.2

ICD-10 Finland

Malignant neoplasm: Hepatoblastoma

+∞

13.5

L01XE29

ATC

[U] lenvatinib

+∞

13.5

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

13.5

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

13.5

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

13.5

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

13.5

360

P01AB01

ATC

metronidazole; oral, rectal

1.4

13.5

800

6241

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

140.7

13.5

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

13.4

121

579

JLB28

NOMESCO Finland

Endoscopic internal drainage of pancreatic duct

21.3

13.3

XF612

NOMESCO Finland

Measurement of central venous pressure

21.3

13.3

L04AX01

ATC

azathioprine; systemic

2.3

13.3

425

GD1AD

NOMESCO Finland

Thorax CT examination

2.1

13.3

123

595

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

13.2

219

3555

A10BG03

ATC

pioglitazone; oral

2.4

13.1

359

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.5

13.0

342

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

13.0

720

5541

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

16.8

13.0

D98

ICPC

Cholecystitis/cholelithiasis

5.2

13.0

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

28.5

13.0

E0000UV, ,

ATC

1.4

12.9

863

6855

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.5

12.9

128

D70.89

ICD-10 Finland

Neutropenic splenomegaly

5.0

12.9

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

12.8

407

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.9

12.8

M04AA01

ATC

allopurinol; systemic

1.5

12.8

416

2892

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.0

12.8

146

763

205

Kela drug reimbursment

Chronic hypertension

1.4

12.7

883

7057

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

70.2

12.6

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.4

12.6

1590

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

12.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

12.5

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

12.5

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

12.5

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

12.5

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

12.5

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

12.5

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

12.5

L02AE04

ATC

triptorelin; parenteral

+∞

12.5

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

12.5

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

12.5

YJ3VG

NOMESCO Finland

MRI examination of abdomen with high intesity magnet for dose design of radiotherapy

+∞

12.5

8140/3-C22.1

ICD-O-3

Adenocarcinoma, NOS, of intrahepatic bile duct

+∞

12.5

8140/3-C22.0

ICD-O-3

Adenocarcinoma, NOS, of liver

+∞

12.5

8010/3-C22.0

ICD-O-3

Carcinoma, NOS, of liver

+∞

12.5

L01BC04

ATC

carmofur; oral

+∞

12.5

ZX121

NOMESCO Finland

Central venous catheter

17.4

12.5

R10.0

ICD-10 Finland

Acute abdomen

2.5

12.5

313

K70.0

ICD-10 Finland

Alcoholic fatty liver

4.0

12.4

A49.8

ICD-10 Finland

Other bacterial infections of unspecified site

4.2

12.4

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

130.6

12.4

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

130.6

12.4

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

5.6

12.4

K74.3

ICD-10 Finland

Primary biliary cirrhosis

5.5

12.1

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

12.1

762

5982

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.9

12.1

K29.6

ICD-10 Finland

Other gastritis

3.4

12.1

124

WPA44, ,

SPAT

26.8

12.0

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

21.4

12.0

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

21.4

12.0

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

3.4

11.9

125

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

11.9

690

5342

J01DB01

ATC

cefalexin; oral

1.4

11.9

1862

16771

B01AF01

ATC

rivaroxaban; oral

0.5

11.8

132

2400

A10BX04

ATC

[U] exenatide

3.6

11.7

107

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

16.5

11.7

JJ1AT

NOMESCO Finland

Puncture of lesion of liver with ultrasound guidance

30.2

11.6

K76.7

ICD-10 Finland

Hepatorenal syndrome

12.6

11.6

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

65.2

11.6

K83.3

ICD-10 Finland

Fistula of bile duct

65.2

11.6

EB1VA, ,

NOMESCO Finland

0.4

11.5

1521

WX419

NOMESCO Finland

Other general anesthesy

4.2

11.5

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

11.5

420

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

11.5

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

11.5

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

+∞

11.5

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

11.5

JK5ZT

NOMESCO Finland

Implantation of bile duct prosthesis with combined percutaneous transhepatic and endoscopic retrograde technic

+∞

11.5

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

11.5

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

11.5

8140/3-C25.0

ICD-O-3

Adenocarcinoma, NOS, of head of pancreas

+∞

11.5

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

11.5

C25.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of pancreas

+∞

11.5

YJ1CD

NOMESCO Finland

Very extensive CT examination of abdomen for dose design of radiotherapy

+∞

11.5

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

120.5

11.4

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

120.5

11.4

R94.5

ICD-10 Finland

Abnormal results of liver function studies

4.1

11.4

SPAT1111

SPAT

Planning of analgesia

3.5

11.3

110

WPA44

NOMESCO Finland

Nursing home for palliative care

35.2

11.3

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

3.1

11.2

151

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

11.1

244

3707

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

11.0

193

1152

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

3.6

11.0

102

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

4.4

11.0

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

43.5

10.9

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

28.1

10.7

JK3MB

NOMESCO Finland

Postoperative cholangiography

28.1

10.7

N05AX08

ATC

risperidone; systemic

0.5

10.7

1702

H01CB03

ATC

lanreotide; parenteral

60.2

10.6

E34.0

ICD-10 Finland

Carcinoid syndrome

60.2

10.6

A28

ICPC

Limited function/disability NOS

1.4

10.6

496

3692

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.5

10.6

105

A07EC02

ATC

mesalazine; oral, rectal

2.0

10.6

109

550

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

10.5

468

6195

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

0.6

10.5

212

3294

ZZA00

NOMESCO Finland

Split skin graft

2.5

10.5

253

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.9

10.5

162

ZXC96

NOMESCO Finland

Robot assisted procedure

4.8

10.5

JJ2CT

NOMESCO Finland

Biopsy of liver with CT guidance

110.5

10.4

C90.0

ICD-10 Finland

Multiple myeloma

110.5

10.4

L02BG03

ATC

anastrozole; oral

110.5

10.4

C50

ICD-10 Finland

Malignant neoplasm of breast

110.5

10.4

L04AA18

ATC

[U] everolimus

110.5

10.4

V03AF03

ATC

calcium folinate; systemic

110.5

10.4

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

10.4

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

10.4

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

10.4

XX7JT

NOMESCO Finland

Somatostatin isotope ablative therapy

+∞

10.4

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

10.4

C77.9

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph node, unspecified

+∞

10.4

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

10.4

8000/3-C25.9

ICD-O-3

Neoplasm, malignant of pancreas, NOS

+∞

10.4

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

10.4

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

10.4

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

10.4

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

10.4

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

10.4

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

+∞

10.4

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

+∞

10.4

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

10.4

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

10.4

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

10.3

175

1035

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

10.3

126

674

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

5.2

10.3

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

10.6

10.3

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

10.3

134

733

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.6

10.2

233

A07AA09

ATC

vancomycin; oral

3.1

10.2

133

PC1BC

NOMESCO Finland

Extensive angiography of aorta and abdominal arteries

7.5

10.2

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.6

10.0

218

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

40.2

10.0

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

40.2

10.0

N06DA02

ATC

donepezil; oral

0.5

10.0

1476

SPAT1088

SPAT

Blood transfusion

5.2

9.8

WPA11

NOMESCO Finland

Developing a plan for palliative care

20.1

9.8

KC1GB

NOMESCO Finland

Cystography with X-ray

20.1

9.8

UJF02

NOMESCO Finland

Peroral enteroscopy

4.9

9.8

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

9.6

9.8

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.7

9.7

511

6595

JFB00

NOMESCO Finland

Partial resection of small intestine

3.2

9.7

116

A10BH05

ATC

linagliptin; oral

1.8

9.7

155

902

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

0.7

9.7

349

4807

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

9.7

159

933

JJ4AT

NOMESCO Finland

Catherisation of liver lesion with ultrasound guidance

55.2

9.6

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

55.2

9.6

E83.50

ICD-10 Finland

Hypercalcemia

3.5

9.6

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

7.8

9.6

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.7

9.6

182

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

9.6

453

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

9.5

138

780

PJA10

NOMESCO Finland

Exploration of lymph nodes

7.1

9.5

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.7

9.5

183

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

9.4

163

970

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.0

9.4

503

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.8

9.4

161

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

9.4

220

1416

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

100.4

9.4

PHN73

NOMESCO Finland

Reconstruction of superior mesenteric or portal vein

100.4

9.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

100.4

9.4

TQW20

NOMESCO Finland

Tatoe

100.4

9.4

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.0

9.4

490

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

7.6

9.4

WPA41

NOMESCO Finland

Psychosocial conversational support in palliative care

30.1

9.4

D13

ICPC

Jaundice

30.1

9.4

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

30.1

9.4

C18.4

ICD-10 Finland

Malignant neoplasm: Transverse colon

+∞

9.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

9.4

128

Kela drug reimbursment

Cancers of female genital organs

+∞

9.4

8246/3-C80.9

ICD-O-3

Neuroendocrine carcinoma, NOS, of unknown primary site

+∞

9.4

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

9.4

1990X

ICD-9 Finland

Malignant neoplasm without specification of site, Disseminated

+∞

9.4

C25.7

ICD-10 Finland

Malignant neoplasm: Other parts of pancreas

+∞

9.4

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

9.4

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

9.4

L02BX02

ATC

degarelix; parenteral

+∞

9.4

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

9.4

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

9.4

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

9.4

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

9.4

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

9.4

L01AX03

ATC

temozolomide; systemic

+∞

9.4

L04AH02

ATC

everolimus; oral

+∞

9.4

SPAT1110

SPAT

Measurement of pain intensity

4.2

9.4

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

12.4

9.3

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

21.8

9.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

9.3

131

734

A10BJ02

ATC

liraglutide; parenteral

2.3

9.3

287

ZXE70

NOMESCO Finland

Moren than 15 and less than 18 hours

8.7

9.3

ZX120, ,

SPAT

3.4

9.2

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

7.7

9.1

TPX15

NOMESCO Finland

Removal of vascular injection port

11.5

9.1

C07AA05

ATC

propranolol; systemic

1.4

9.0

359

2589

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

9.0

108

576

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

8.9

145

848

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

8.8

149

881

OAB43, ,

SPAT

0.5

8.8

1530

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

8.8

125

703

J01FF01

ATC

clindamycin; systemic

1.4

8.7

567

4440

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

8.7

114

625

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

8.7

121

676

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.1

8.7

119

EB4VA, ,

NOMESCO Finland

0.4

8.7

951

UJK52

NOMESCO Finland

Endoscopy of biliary tract in connection with endoscopic retrograde cholangiopancreatography

50.2

8.7

JLA00

NOMESCO Finland

Exploration of pancreas

50.2

8.7

QX9VV, ,

NOMESCO Finland

50.2

8.7

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

4.3

8.7

R83

ICPC

Respiratory infection other

0.6

8.5

151

2426

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.4

8.5

248

ZY010

NOMESCO Finland

Hospital outpatient

2.2

8.5

331

D69.5

ICD-10 Finland

Secondary thrombocytopenia

10.1

8.5

JMA10

NOMESCO Finland

Transabdominal total splenectomy

10.1

8.5

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

8.5

1009

8579

JLD12

NOMESCO Finland

Endoscopic drainage of pancreatic pseudocyst

27.6

8.5

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

27.6

8.5

I86.4

ICD-10 Finland

Gastric varices

20.1

8.5

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.8

8.4

129

742

C25

ICD-10 Finland

Malignant neoplasm of pancreas

90.3

8.4

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

8.4

223

1480

TQW99

NOMESCO Finland

Other minor procedure on skin

2.0

8.4

414

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.7

8.4

155

A10AD05

ATC

insulin aspart; parenteral

2.2

8.3

334

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

8.3

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

8.3

1560A

ICD-9 Finland

Malignant neoplasm of gallbladder and extrahepatic bile ducts, Gallbladder

+∞

8.3

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

8.3

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

+∞

8.3

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

8.3

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

8.3

L02BB04

ATC

enzalutamide; oral

+∞

8.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

8.3

1551A

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Intrahepatic bile ducts

+∞

8.3

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

8.3

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

8.3

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

8.3

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

8.3

WPA43

NOMESCO Finland

A doctor's home visit to perform palliative care

+∞

8.3

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

8.3

C18.2

ICD-10 Finland

Malignant neoplasm: Ascending colon

+∞

8.3

C17.2

ICD-10 Finland

Malignant neoplasm: Ileum

+∞

8.3

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

+∞

8.3

L01CB01

ATC

etoposide; systemic

+∞

8.3

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.0

8.3

450

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

8.2

116

651

WX610

NOMESCO Finland

Patient controlled analgesia

7.1

8.2

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.7

8.2

522

6576

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

8.2

245

1668

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

8.2

466

UJD02

NOMESCO Finland

Gastroscopy

1.8

8.2

118

668

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.8

8.1

146

L01

ICPC

Neck symptom/complaint

0.6

8.1

117

1979

R01AD58

ATC

fluticasone, combinations; nasal

0.6

8.1

171

2631

JG1CG

NOMESCO Finland

Extensive MRI of rectum

22.1

8.0

JLB12

NOMESCO Finland

Transduodenal endoscopic incision of pancreatic duct orifice

22.1

8.0

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

22.1

8.0

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

22.1

8.0

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

8.0

492

3818

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.2

8.0

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

3.2

8.0

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.6

7.9

177

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

4.0

7.9

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

3.1

7.8

100

RD210, ,

NOMESCO Finland

3.0

7.8

116

SPAT1122

SPAT

Ascites puncture

45.1

7.7

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

45.1

7.7

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

45.1

7.7

I85

ICD-10 Finland

Oesophageal varices

45.1

7.7

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

15.1

7.7

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

7.6

242

JFC00

NOMESCO Finland

Entero-enterostomy

18.4

7.6

JLC10

NOMESCO Finland

Distal pancreatectomy

18.4

7.6

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

8.0

7.6

JLW98

NOMESCO Finland

Other transluminal endoscopic operation on pancreas

11.9

7.6

JK3AT

NOMESCO Finland

Catherisation of bile duct with ultrasound guidance

25.1

7.6

K51.8

ICD-10 Finland

Other ulcerative colitis

2.9

7.5

113

F03

ICD-10 Finland

Unspecified dementia

0.5

7.5

1112

K74.0

ICD-10 Finland

Hepatic fibrosis

8.9

7.5

N03AX16

ATC

[U] pregabalin

1.3

7.5

468

3633

HAB99

NOMESCO Finland

Other partial excision of mammary gland

6.2

7.5

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

10.0

7.5

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

3.8

7.5

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

0.5

7.5

1616

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.7

7.5

120

701

K65.0

ICD-10 Finland

Acute peritonitis

2.9

7.5

119

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.1

7.4

WPA13, ,

SPAT

80.3

7.4

XW2AT

NOMESCO Finland

Cytology of deep organ with ultrasound quidance

80.3

7.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

80.3

7.4

L15

ICPC

Knee symptom/complaint

0.7

7.4

274

3772

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

6.5

7.4

PC1CC

NOMESCO Finland

Very extensive angiography of aorta and abdominal arteries

7.7

7.4

WZA10

NOMESCO Finland

Extensive medical or dental certificate

3.3

7.4

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

6.0

7.4

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

4.0

7.3

N06DA03

ATC

rivastigmine; oral, transdermal

0.4

7.3

991

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

7.3

K62.7

ICD-10 Finland

Radiation proctitis

+∞

7.3

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

7.3

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

7.3

8010/3-C80.9

ICD-O-3

Carcinoma, NOS, of unknown primary site

+∞

7.3

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

7.3

C25.3

ICD-10 Finland

Malignant neoplasm: Pancreatic duct

+∞

7.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

7.3

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

7.3

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

7.3

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

7.3

L01CA04

ATC

vinorelbine; systemic

+∞

7.3

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

7.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

7.3

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

7.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

7.3

JJB00

NOMESCO Finland

Wedge resection of liver

+∞

7.3

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

7.3

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

7.3

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

7.3

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

7.3

8500/3-C25.0

ICD-O-3

Infiltrating duct carcinoma, NOS, of head of pancreas

+∞

7.3

KCC10

NOMESCO Finland

Cystoprostatectomy

+∞

7.3

8010/3-C23.9

ICD-O-3

Carcinoma, NOS, of gallbladder

+∞

7.3

K74

ICD-10 Finland

Fibrosis and cirrhosis of liver

+∞

7.3

JJA40

NOMESCO Finland

Excision of lesion of liver

+∞

7.3

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

7.3

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

7.3

1552A

ICD-9 Finland

Malignant neoplasm of liver and intrahepatic bile ducts, Liver, not specified as primary or secondary[NEOPLASMA MALIGNUM HEPATIS, PRIMARIUM ALIUD]

+∞

7.3

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

6.8

7.3

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.7

7.3

138

JWA00

NOMESCO Finland

Repair of wound dehiscence in gastroenterological surgery

4.3

7.2

XX1AD

NOMESCO Finland

Other CT-examination

30.1

7.1

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

30.1

7.1

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.1

7.1

D02

ICPC

Abdominal pain epigastric

1.8

7.1

105

599

A10BB01

ATC

glibenclamide; oral

1.6

7.1

173

1126

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.4

7.1

910

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

7.1

105

600

M25.5

ICD-10 Finland

Pain in joint

0.7

7.1

356

4657

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

10.0

7.0

JCF12

NOMESCO Finland

Endoscopic insertion of prosthetic tube into oesphagus

10.0

7.0

JFF10

NOMESCO Finland

Loop enterostomy

10.0

7.0

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

10.0

7.0

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

7.0

491

3878

TDA90, ,

SPAT

0.4

7.0

777

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

7.0

I21.9

ICD-10 Finland

Acute myocardial infarction, unspecified

0.3

7.0

536

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.7

6.9

130

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.0

6.9

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

6.9

1143

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.7

6.9

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

3.7

6.9

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

0.6

6.9

100

1690

S77

ICPC

Malignant neoplasm of skin

13.8

6.9

OAA67, ,

SPAT

0.4

6.8

866

JDH35

NOMESCO Finland

Endoscopic insertion of duodenal stent

40.2

6.8

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

40.2

6.8

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.9

6.7

462

SPAT1053

SPAT

Memory test

0.7

6.7

242

3352

WZC15, ,

NOMESCO Finland

16.7

6.7

B02AA02

ATC

tranexamic acid; systemic

1.5

6.7

188

1263

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

0.6

6.7

121

1934

M01AH05

ATC

etoricoxib; oral

0.8

6.7

929

10670

JCA20

NOMESCO Finland

Ligature of oesophageal varices

22.6

6.7

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

22.6

6.7

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

6.7

464

K50.8

ICD-10 Finland

Other Crohn disease

3.0

6.7

K82.9

ICD-10 Finland

Disease of gallbladder, unspecified

7.8

6.6

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

12.3

6.6

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

12.3

6.6

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.8

6.5

474

207

Kela drug reimbursment

Chronic arrhythmias

0.7

6.5

273

3679

Z31.5

ICD-10 Finland

Genetic counselling

2.2

6.5

221

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

70.0

6.4

6603

FHL

Delete a block

70.0

6.4

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

70.0

6.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

70.0

6.4

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

70.0

6.4

JN4DD

NOMESCO Finland

Scout CT scan of torso

70.0

6.4

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

6.4

445

5565

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.9

6.4

370

KGH10

NOMESCO Finland

Operation for phimosis

1.9

6.4

364

A10BH02

ATC

vildagliptin; oral

2.1

6.4

275

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.1

6.4

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

6.3

153

995

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.0

6.3

323

M05BX04

ATC

denosumab; parenteral

1.8

6.3

568

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

6.6

6.3

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.7

6.3

201

2848

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

6.3

103

606

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

6.3

415

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

11.0

6.3

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.5

6.3

K81.9

ICD-10 Finland

Cholecystitis, unspecified

2.6

6.3

137

N05BA04

ATC

oxazepam; oral

1.3

6.3

542

4398

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.9

6.3

387

D01

ICPC

Abdominal pain/cramps general

1.5

6.3

182

1233

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

6.3

8010/3-C22.1

ICD-O-3

Carcinoma, NOS, of intrahepatic bile duct

+∞

6.3

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

6.3

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

6.3

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

6.3

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

6.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

6.3

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

6.3

C18.50

ICD-10 Finland

Malignant tumor in flexural lienalis without histology

+∞

6.3

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

6.3

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

6.3

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

6.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

6.3

WD215

NOMESCO Finland

Multiple therapy of methastized malignancy with hormones

+∞

6.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

6.3

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

6.3

JFA65

NOMESCO Finland

Endoscopic insertion of ileum stent

+∞

6.3

JA3GT

NOMESCO Finland

Insertion of tunnelled ascites drain

+∞

6.3

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

6.3

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

6.3

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

6.3

C18.1

ICD-10 Finland

Malignant neoplasm: Appendix

+∞

6.3

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

6.3

C49.49

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor

+∞

6.3

WPA15, ,

SPAT

+∞

6.3

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

+∞

6.3

WPA12

NOMESCO Finland

A meeting to support loved ones after the patient's death

+∞

6.3

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

+∞

6.3

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

6.3

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

6.3

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

6.3

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

6.3

C48.80

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum without histology

+∞

6.3

8180/3-C22.0

ICD-O-3

Combined hepatocellular carcinoma and cholangiocarcinoma of liver

+∞

6.3

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

6.3

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

6.3

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

6.3

C26.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of digestive system

+∞

6.3

WGA10

NOMESCO Finland

Measurement of pain intensity

+∞

6.3

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

6.3

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

6.3

C76.8

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites

+∞

6.3

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

6.3

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

6.3

1562A

ICD-9 Finland

Malignant neoplasm of gallbladder and extrahepatic bile ducts, Ampulla of Vater

+∞

6.3

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

6.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

6.3

T73

ICPC

Neoplasm endocrine other/unspecified

+∞

6.3

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

+∞

6.3

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

6.3

8500/3-C25.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of pancreas, NOS

+∞

6.3

K56.7

ICD-10 Finland

Ileus, unspecified

2.3

6.2

186

NG1AA, ,

SPAT

0.3

6.2

547

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

26.7

6.2

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

26.7

6.2

K76.6

ICD-10 Finland

Portal hypertension

26.7

6.2

SDA01

NOMESCO Finland

Periodontal treatment, very brief

0.7

6.2

269

3609

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

3.7

6.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

6.2

230

1638

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

7.7

6.1

L13

ICPC

Hip symptom/complaint

0.7

6.1

218

3024

WX872

NOMESCO Finland

Intensive care

1.6

6.1

130

821

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.8

6.1

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

12.5

6.1

L03

ICPC

Low back symptom/complaint

0.7

6.1

314

4098

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.9

6.0

D99

ICPC

Disease digestive system other

3.1

6.0

ZXE90

NOMESCO Finland

More than 22 hours

3.1

6.0

358

Kela drug reimbursment

liraglutide

3.6

6.0

K31.5

ICD-10 Finland

Obstruction of duodenum

10.0

6.0

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

10.0

6.0

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.0

6.0

295

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768441) Liver Pathology biopsy report

450

93.17

307.65

1.6

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

430

433

11.65

307.65

1.5

1.2

103.03

94.67

titre

0.08

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

926

392

35.70

307.65

5.0

1.8

2067.81

28.64

u/ml

2.08

844

309

(3023183) Ammonium ion [Moles/volume] in Plasma

491

425

13.94

307.65

4.4

2.5

42.93

36.13

umol/l

1.93

460

374

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1020

1468

10.65

307.65

5.2

2.0

0.17

0.20

g/l

16.00

965

1320

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

642

199

42.20

307.65

4.9

1.9

1054.78

24.50

u/ml

3.19

609

180

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1455

1044

29.54

307.65

5.2

1.4

34.15

2.75

ug/l

3.91

1298

778

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

245

29.55

307.65

1.5

1.3

—

(4035726) Immunohistochemistry procedure

596

465

16.23

307.65

1.5

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

298

220

15.13

307.65

1.3

1.1

1.66

1.53

g/l

3.50

281

186

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1000

1875

7.94

307.65

9.5

2.2

28.03

8.03

umol/l

20.68

940

1609

(3024561) Albumin [Mass/volume] in Serum or Plasma

1748

8306

4.22

278.19

13.6

3.8

31.40

35.14

g/l

110.39

1693

7542

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

154

60.48

275.99

3.6

2.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

621

1374

5.59

274.20

1.6

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1874

9433

4.34

272.38

24.2

3.7

26.16

12.51

umol/l

30.00

1842

8801

(3020779) Urea [Moles/volume] in Serum or Plasma

723

1905

4.84

258.51

10.0

6.7

8.40

11.46

mmol/l

20.19

700

1789

(3017143) Hepatitis C virus Ab [Presence] in Serum

595

1333

5.46

258.04

1.6

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1414

6100

3.81

252.61

6.2

2.2

71.54

60.51

u/l

0.75

1371

5576

(3033658) Prothrombin time (PT) actual/Normal

1164

4497

3.82

243.89

12.6

3.6

76.65

83.02

13.87

1140

4367

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1308

5590

3.64

232.32

10.7

2.6

67.03

38.51

u/l

8.12

1268

5260

(3012095) Magnesium [Moles/volume] in Serum or Plasma

859

2881

3.93

218.14

5.0

2.5

0.77

0.82

mmol/l

28.73

827

2621

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

171

127

14.32

184.76

1.6

1.2

—

(3023368) Bacteria identified in Blood by Culture

1249

5801

3.17

182.80

6.6

3.9

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

561

1561

4.29

181.95

6.1

2.2

42.53

38.00

u/l

0.37

508

1293

(3022217) INR in Platelet poor plasma by Coagulation assay

1781

10336

3.19

172.11

20.8

19.7

1.31

1.40

inr

3.81

498

2836

(3044640) Blood type and Crossmatch panel - Blood

1172

5441

3.06

168.49

3.9

2.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

119

24.38

166.61

2.1

2.5

7072.33

792.30

e6/l

0.51

(3002256) Pathology report gross observation

463

1262

4.23

152.76

1.5

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

390

931

4.74

152.71

1.7

1.4

1.36

1.12

g/l

2.11

351

833

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

951

4175

2.99

147.38

3.8

2.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1461

8146

2.76

141.85

4.4

2.4

—

(3033799) Differential panel - Peritoneal fluid

102

23.53

141.05

2.0

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

425

1160

4.17

139.31

2.2

2.1

12.62

10.86

g/l

8.70

385

1049

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

100

23.58

138.41

2.0

2.2

1951.97

45453.81

e6/l

0.58

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

105

19.83

135.11

4.0

2.1

—

(3044007) Cell count panel - Peritoneal fluid

24.67

131.06

2.0

2.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

697

2796

3.02

124.14

2.6

2.7

23.61

22.46

0.95

636

2341

(3021879) Hepatitis B virus core Ab [Presence] in Serum

318

776

4.52

120.09

1.3

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

511

1759

3.36

117.53

2.3

1.7

1.62

1.59

0.48

444

1482

(3004789) Transferrin [Mass/volume] in Serum or Plasma

706

2976

2.87

113.67

2.5

2.6

2.28

2.27

g/l

0.24

668

2723

(3042936) Bacteria identified in Isolate by Culture

665

2719

2.93

113.26

2.6

2.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1617

10174

2.50

112.12

18.5

6.1

4.27

4.46

e9/l

2.03

1463

8682

(3022948) Iron [Moles/volume] in Serum or Plasma

742

3237

2.79

111.67

2.6

12.54

12.74

umol/l

0.28

714

2969

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

205

369

5.94

109.77

1.2

1.3

—

(3042733) HLA Ab [Presence] in Serum

18.88

108.39

1.3

4.5

—

(3024471) HLA-A [Type]

18.88

108.39

1.0

—

(3024932) HLA-DR beta [Type]

19.05

107.61

1.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

165

244

7.14

107.05

8.0

5.0

1181.92

635.27

iu/ml

0.71

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

218

427

5.47

106.57

3.7

2.3

2.94

3.50

g/l

4.78

211

401

(3000570) Elastase.pancreatic [Mass/mass] in Stool

236

511

4.97

102.81

1.5

176.50

283.85

ug/g

10.08

144

311

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

125

142

9.19

101.20

1.4

1.2

149.00

174.44

titre

0.11

(3026692) Albumin [Mass/volume] in Peritoneal fluid

18.71

100.48

1.6

1.5

10.84

15.11

g/l

1.85

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

538

2086

2.98

99.73

3.8

2.7

258.76

236.74

u/l

1.25

520

1926

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

106

102

10.78

96.81

2.3

2.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

105

101

10.78

95.92

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

171

304

5.94

92.56

2.2

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

703

3253

2.58

91.69

2.7

1.9

31.50

30.15

5.48

690

3148

(40768804) Tissue Pathology biopsy report

999

5489

2.31

88.30

2.7

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

15.52

88.14

37.1

33.1

7.10

7.43

ug/l

0.54

(3003458) Phosphate [Moles/volume] in Serum or Plasma

598

2612

2.66

87.30

6.5

5.3

1.04

mmol/l

0.00

566

2370

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1522

9962

2.23

87.25

9.8

5.6

1.19

1.21

mmol/l

18.09

1315

8427

(3006922) Hepatitis E virus Ab [Presence] in Serum

10.56

85.68

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

204

457

4.75

85.03

6.0

2.8

1.61

1.72

mg/l

0.84

189

399

(3002331) Protein [Mass/volume] in Peritoneal fluid

20.17

84.52

1.2

1.4

46.75

28.74

g/l

0.30

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

10.79

84.31

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

10.79

84.31

1.1

1.0

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1409

9022

2.19

84.28

8.8

5.3

1.19

1.21

mmol/l

16.31

1352

8006

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

149

260

6.01

82.12

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

142

241

6.17

80.49

1.3

1.2

350.11

293.44

u/ml

0.96

148

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1653

11397

2.19

80.32

10.3

3.0

218.06

51.63

u/l

84.68

1577

10329

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

326

1066

3.35

79.82

10.1

9.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

140

242

6.05

77.88

1.3

1.4

112.17

112.77

u/ml

0.02

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

142

252

5.90

76.87

1.1

—

(3018418) pH of Serum or Plasma

992

5688

2.19

76.61

5.2

3.3

7.41

7.40

1.17

222

965

(3013826) Glucose [Moles/volume] in Serum or Plasma

1694

11949

2.15

75.46

10.3

4.4

7.44

6.94

mmol/l

13.07

1646

11176

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

147

282

5.46

73.19

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

474

2002

2.66

72.89

9.4

6.9

116.62

122.15

g/l

6.66

461

1953

(3016650) Hepatitis A virus Ab [Presence] in Serum

130

223

6.08

72.85

1.1

1.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1039

6161

2.13

72.71

6.7

2.1

2.33

2.35

mmol/l

3.36

974

5112

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

146

282

5.42

72.14

1.3

—

18.26

—

(3014007) Fractional oxyhemoglobin in Arterial blood

352

1278

3.02

71.92

10.1

8.3

95.18

93.26

10.36

352

1271

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

322

1111

3.16

71.86

9.4

7.1

24.05

24.77

mmol/l

2.73

316

1099

(4281824) Cell count and differential, peritoneal fluid

10.04

71.56

1.3

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

543

2477

2.50

71.01

8.8

6.3

13.03

11.36

kpa

12.44

519

2345

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

543

2477

2.50

71.01

8.8

6.4

5.00

5.04

kpa

0.48

521

2349

(3016502) Oxygen saturation in Arterial blood

506

2238

2.56

70.62

9.1

6.6

96.86

94.82

14.59

491

2147

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

240

702

3.66

69.58

2.8

0.29

0.34

u/ml

1.50

121

416

(3048929) Epstein Barr virus Ab [Presence] in Serum

158

339

4.89

69.19

1.3

1.2

—

(3000991) Gas panel - Venous blood

421

1717

2.72

69.14

10.2

7.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

206

545

4.01

68.97

1.9

1.7

—

(3003396) Base excess in Arterial blood by calculation

537

2468

2.47

68.91

8.8

6.4

0.40

1.20

mmol/l

5.01

440

1918

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

130

237

5.72

68.35

1.1

1.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

359

1376

2.86

66.23

1.8

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1926

14661

2.14

65.08

26.4

5.3

170.77

76.79

u/l

108.74

1884

13504

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

689

3627

2.21

63.95

7.0

2.2

2.50

2.45

mmol/l

22.45

646

3065

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

158

369

4.49

62.30

2.3

1.5

139.52

22.47

u/ml

3.21

152

349

(3010375) cycloSPORINE [Mass/volume] in Blood

10.88

62.03

31.5

23.8

130.06

123.69

ug/l

0.23

(3014111) Lactate [Moles/volume] in Serum or Plasma

424

1833

2.56

61.44

8.7

6.2

1.79

1.44

mmol/l

3.38

412

1772

(40758558) Short blood count panel - Blood

767

4277

2.11

61.01

13.3

4.6

—

(3003694) ABO and Rh group [Type] in Blood

773

4378

2.08

58.60

1.5

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

253

863

3.13

57.15

2.2

1.7

2.61

1.62

ug/l

0.67

237

732

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

103

179

5.95

56.89

2.8

2.6

185.17

280.50

u/ml

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

328

1295

2.75

56.81

10.4

8.1

1.35

1.38

0.32

328

1284

(3002582) Erythrocytes [#/volume] in Urine

969

6009

1.96

56.50

3.9

3.1

60.79

71.77

e6/l

0.29

781

4606

(3024980) IgG subclass 4 [Mass/volume] in Serum

124

258

4.99

56.22

2.1

1.7

0.77

0.94

g/l

0.77

201

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

129

6.94

56.09

1.1

1.0

282.80

287.36

mg/l

0.17

114

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

123

257

4.97

55.49

6.6

6.4

11.98

12.16

mg/l

0.12

112

234

(3030467) Casts [#/volume] in Urine by Automated count

897

5452

1.97

55.18

3.7

3.0

0.89

0.47

e6/l

2.89

717

4154

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

281

1044

2.89

54.50

11.2

8.5

23.70

24.29

mmol/l

2.51

274

990

(3019069) Monocytes/100 leukocytes in Blood

1256

8606

1.87

53.06

7.5

5.8

9.28

8.91

2.87

1188

7894

(3002030) Lymphocytes/100 leukocytes in Blood

1274

8769

1.87

53.05

7.4

5.6

23.03

26.30

19.13

1208

8076

(40760892) CBC W Ordered Manual Differential panel - Blood

1235

8506

1.84

50.51

7.6

5.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

640

3547

2.06

50.35

2.1

1.8

—

(3006504) Eosinophils/100 leukocytes in Blood

1238

8565

1.83

49.61

7.3

5.5

2.53

3.01

11.53

1172

7848

(3022096) Basophils/100 leukocytes in Blood

1208

8312

1.83

49.13

7.3

5.5

0.59

0.66

4.80

1139

7609

(40768797) Stomach Pathology biopsy report

507

2597

2.18

48.92

1.4

1.2

—

(36304419) Bacteria [Presence] in Urine

850

5248

1.91

48.68

3.7

3.0

—

(3019198) Lymphocytes [#/volume] in Blood

1327

9435

1.81

48.06

7.1

5.3

1.56

1.82

e9/l

14.63

1172

8167

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

12.57

47.87

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

12.25

47.11

1.1

—

(3006315) Basophils [#/volume] in Blood

1302

9256

1.80

46.71

7.1

5.2

0.04

e9/l

5.22

1120

7879

(3018010) Neutrophils/100 leukocytes in Blood

1237

8673

1.80

46.40

7.1

5.5

60.78

58.49

7.54

1172

7986

(3001604) Monocytes [#/volume] in Blood

1295

9220

1.79

45.96

7.1

5.2

0.63

e9/l

0.11

1121

7842

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

262

1028

2.72

45.58

4.4

3.8

23.09

24.12

mmol/l

4.42

257

990

(3026782) Osmolality of Urine

683

4019

1.94

44.56

3.5

2.8

543.15

549.06

mosm/kgh2o

0.30

624

3386

(3021447) Carbon dioxide [Partial pressure] in Venous blood

431

2147

2.20

44.24

4.4

3.5

5.52

5.85

kpa

8.27

421

2061

(46235355) HIV 1 and 2 tests - Meaningful Use set

361

1679

2.33

43.67

1.4

1.5

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

557

3080

2.02

43.33

3.2

2.8

2.23

2.12

e6/l

0.10

322

1707

(3002032) Base excess in Venous blood by calculation

428

2144

2.19

43.26

4.4

3.5

1.15

2.00

mmol/l

4.61

339

1779

(3013115) Eosinophils [#/volume] in Blood

1320

9568

1.75

43.01

7.4

5.4

0.17

0.21

e9/l

11.19

1150

8230

(3018095) Leukocytes [#/volume] in Urine

1025

6925

1.78

42.56

4.5

3.5

74.78

117.14

e6/l

1.79

813

4944

(40768795) Lymph node Pathology biopsy report

14.26

41.67

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

6.66

38.75

1.1

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

433

2285

2.07

37.85

1.5

1.3

325.00

530.56

titre

3.52

519

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

456

2473

2.02

36.90

2.0

1.8

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

570

3341

1.90

36.70

3.0

2.7

1.19

1.31

e6/l

0.27

333

1959

(3007164) IgA [Mass/volume] in Serum or Plasma

522

2975

1.94

36.58

1.7

1.3

3.68

2.75

g/l

10.87

398

1666

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

455

2477

2.01

36.39

2.0

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

678

4218

1.82

36.01

3.1

2.4

5.80

4.58

e6/l

1.89

638

3737

(3036489) Thrombin time

172

616

2.92

35.37

2.7

1.8

23.14

21.35

6.00

166

550

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

389

2066

2.03

33.11

4.5

3.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1605

12780

1.64

32.82

5.3

4.5

1478.25

2453.24

e6/l

0.48

229

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

277

1296

2.27

32.64

1.6

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

129

5.22

32.14

1.0

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

793

5354

1.69

30.71

2.7

2.3

3.56

2.97

mg/l

5.98

700

4485

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

302

1556

2.06

27.69

4.8

3.0

1.21

1.22

mmol/l

2.05

282

1306

(3017181) Myelocytes/100 leukocytes in Blood

283

1425

2.10

27.59

4.4

3.7

1.19

0.85

1.18

167

401

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

5.96

26.52

1.6

1.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

232

3.71

26.35

2.9

2.8

2.04

1.37

0.76

195

(3026008) Bacteria identified in Urine by Culture

849

6056

1.59

25.40

3.1

3.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1004

7451

1.56

25.23

3.4

2.8

202.29

144.43

ug/l

6.26

932

6755

(3008152) Bicarbonate [Moles/volume] in Arterial blood

282

1469

2.03

25.00

7.3

6.3

23.65

24.44

mmol/l

2.67

267

1405

(3019060) Gas panel - Arterial blood

286

1525

1.98

23.70

5.4

4.3

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

5.51

22.90

3.0

2.7

45081.82

41745.68

ug/l

0.62

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

277

3.25

22.61

1.2

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

220

3.53

22.27

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1660

19024

0.66

22.03

5.1

4.8

4.25

4.43

mmol/l

8.67

1488

17362

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1717

19543

0.66

22.01

5.4

2.45

2.58

mmol/l

6.85

1519

17755

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1640

18830

0.66

21.83

5.0

4.8

1.30

1.41

mmol/l

19.47

1450

17051

(3002179) Metamyelocytes/100 leukocytes in Blood

250

1311

2.00

21.67

4.3

3.6

0.77

0.67

0.32

141

354

(3012501) Base excess in Blood by calculation

117

446

2.70

21.39

4.8

4.6

2.27

2.68

mmol/l

1.02

292

(3007930) Methemoglobin/Hemoglobin.total in Blood

194

930

2.17

21.36

6.3

4.3

0.86

0.01

180

879

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

286

1580

1.91

21.28

3.9

2.4

65.75

61.64

ml/min/173m2

0.74

124

619

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

195

946

2.15

20.83

6.3

4.2

1.72

1.61

0.69

183

894

(3021440) Promyelocytes/100 leukocytes in Blood

255

1373

1.95

20.46

4.6

3.7

0.14

0.07

0.76

143

350

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

166

3.80

20.39

1.1

1.2

57.98

53.24

u/l

0.29

146

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

21.75

19.48

1.2

1.3

1.70

0.82

ml/s/173m2

—

(3010421) pH of Blood

126

524

2.47

19.30

4.8

4.5

7.43

7.42

2.04

115

469

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1690

19136

0.68

19.04

5.3

5.0

6.51

6.12

mmol/l

18.43

1509

17155

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

20.97

18.60

1.6

1.3

24.67

15.88

—

(3024354) Oxygen [Partial pressure] in Venous blood

305

1796

1.79

18.41

4.0

3.0

4.68

4.49

kpa

0.90

297

1716

(3047181) Lactate [Moles/volume] in Blood

148

677

2.26

18.28

7.2

5.2

1.73

1.33

mmol/l

1.61

126

601

(3027945) Reticulocytes/100 erythrocytes in Blood

405

2598

1.66

17.91

2.6

2.1

1.99

1.75

3.22

361

2246

(3000494) Fungus identified in Specimen by Culture

346

2139

1.71

17.57

1.8

1.4

—

(3018572) Chloride [Moles/volume] in Blood

112

461

2.49

17.55

8.4

5.9

105.93

105.06

mmol/l

1.56

100

417

(3039000) Anion gap in Blood

112

461

2.49

17.55

8.3

5.9

11.85

11.36

mmol/l

0.65

100

417

(1616796) Gas panel - Central venous blood

111

455

2.50

17.55

3.3

3.9

—

(3025159) Blasts/100 leukocytes in Blood

236

1303

1.89

17.51

4.5

3.9

0.06

0.07

0.13

119

286

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1604

18242

0.70

17.44

4.6

4.3

1.37

1.29

mmol/l

4.43

1419

16363

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

238

1329

1.87

17.04

1.7

—

(3022145) Colonoscopy Study observation

298

1792

1.75

16.68

1.6

1.3

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

260

1508

1.80

16.46

2.7

1.8

400.89

365.80

nmol/l

1.67

241

1346

(3021589) Normoblasts [#/volume] in Blood

1014

8066

1.42

15.86

20.6

8.7

0.00

e9/l

0.40

810

6520

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

14.57

15.82

1.3

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

15.64

1.0

0.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1559

13389

1.40

15.32

5.1

4.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4.20

14.13

2.0

1.3

17.01

68.90

u/l

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

306

2.63

14.08

3.5

3.2

58.89

59.09

0.04

306

(3008757) Leukocyte morphology finding [Identifier] in Blood

185

3.13

14.02

2.7

3.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

4.68

14.00

1.7

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

374

2.46

13.87

2.0

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

392

2.40

13.44

1.9

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

100

443

2.31

13.38

2.7

2.5

14.82

16.48

2.70

239

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

276

2.65

13.12

2.0

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

126

621

2.08

12.95

1.4

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1668

18515

0.73

12.57

8.6

6.6

43.49

41.12

mmol/mol

13.26

1516

16908

(3017354) Segmented neutrophils/100 leukocytes in Blood

162

3.13

12.37

3.1

2.7

59.42

59.78

0.03

130

(3025941) Bacteria identified in Stool by Culture

166

915

1.87

12.37

1.2

—

(1761868) Lipid panel - Serum or Plasma

412

5720

0.67

12.36

3.6

3.3

—

(3018405) Lactate [Moles/volume] in Arterial blood

154

831

1.91

12.25

4.0

3.8

1.86

1.48

mmol/l

1.27

154

812

(3020891) Body temperature

168

938

1.84

12.03

5.0

4.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

13.42

11.93

1.2

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

374

2.31

11.59

1.5

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

118

3.43

11.51

1.6

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

164

3.03

11.50

1.6

1.4

0.46

0.41

g/l

0.34

123

(3027135) IgG subclass 1 [Mass/volume] in Serum

164

3.03

11.50

1.6

1.4

7.51

7.00

g/l

0.26

123

(3028192) IgG subclass 2 [Mass/volume] in Serum

164

3.03

11.50

1.6

1.4

3.22

2.97

g/l

0.27

123

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

372

5205

0.67

11.48

2.0

1.6

1.51

1.33

mmol/l

3.13

331

4311

(3023520) Reticulocytes [#/volume] in Blood

295

1947

1.58

11.38

2.6

2.1

75.68

67.81

e9/l

2.37

228

1490

(4062490) Immunoglobulin typing, IgG

165

3.01

11.38

1.6

1.4

—

(3051651) Icteric interference index of Serum or Plasma

100

3.64

11.34

2.5

4.2

—

(3003181) Sodium [Moles/volume] in Urine

359

2.32

11.32

1.4

53.89

63.87

mmol/l

1.19

280

(3035637) Corticotropin [Mass/volume] in Plasma

150

3.10

11.29

2.0

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

184

2.86

11.07

2.7

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

301

2.43

11.02

3.2

3.1

4.26

4.59

e9/l

0.36

301

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

633

8008

0.73

10.91

3.8

22.44

24.48

2.26

293

3900

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

176

1027

1.76

10.90

1.7

1.6

1.40

1.53

g/l

1.03

144

877

(3007853) Bacteria identified in Skin by Aerobe culture

332

2281

1.52

10.68

1.9

1.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.37

10.51

2.5

2.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1583

17533

0.76

10.36

4.6

4.4

2.35

2.10

mu/l

1.90

1403

15665

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

178

1058

1.73

10.34

2.9

2.7

1.18

1.20

0.17

178

1049

(3027273) Bicarbonate [Moles/volume] in Venous blood

195

1194

1.68

10.17

3.7

3.0

23.94

25.17

mmol/l

4.37

189

1144

(40761536) Microorganisms panel - Urine sediment

227

1450

1.62

10.03

4.8

3.8

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

173

1037

1.71

9.76

2.9

2.6

0.70

0.65

1.10

173

1030

(3020630) Protein [Mass/volume] in Serum or Plasma

266

1777

1.55

9.71

2.1

1.6

65.86

66.55

g/l

0.64

240

1565

(40768793) Breast Pathology biopsy report

4.03

9.50

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

214

2.55

9.30

1.6

1.5

27852.61

61126.15

e6/l

0.57

131

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

104

3.30

9.30

1.6

1.5

2.15

7.32

u/l

2.73

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

110

584

1.92

9.25

1.5

1.4

21.04

18.63

iu/ml

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

190

2941

0.62

9.23

1.2

1.3

45.25

40.95

iu/ml

0.10

901

(3043410) Blood group antigens tested for on Red Blood Cells

4.59

9.06

2.0

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

236

2.45

8.97

1.8

1.4

—

(40768806) Pleura Pathology biopsy report

184

2.64

8.85

1.8

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

107

572

1.91

8.83

3.7

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

103

1851

0.54

8.81

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.03

8.78

2.3

2.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

421

5525

0.72

8.75

2.7

0.73

ug/l

0.03

294

3817

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

180

2.64

8.69

1.9

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

179

1118

1.64

8.67

3.1

2.5

0.94

0.34

e6/l

1.70

179

1092

(3023199) Leukocytes [#/volume] in Pleural fluid

240

2.41

8.66

1.6

1.5

1104.73

1492.30

e6/l

0.37

173

(3011412) CD3 cells [#/volume] in Blood

3.36

8.48

2.2

2.1

1.12

e9/l

0.01

(3045142) Bone marrow Pathology biopsy report

132

2.91

8.44

1.4

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1016

8662

1.28

8.34

4.4

4.1

38.83

98.97

ng/l

1.90

854

6626

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

463

1.98

8.33

1.6

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

223

2.40

8.09

1.7

1.2

—

(3045788) Cell count panel - Pleural fluid

184

2.53

7.83

1.7

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

215

2.40

7.77

1.8

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

216

2.39

7.69

1.8

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

867

7308

1.28

7.64

3.1

3.2

1418.65

1741.56

ng/l

1.13

765

6304

(1175426) CD3 cells/100 lymphocytes in Blood

3.61

7.57

1.6

2.3

69.87

70.65

0.07

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

553

4400

1.32

7.53

3.9

4.2

465.64

521.99

ng/l

0.12

472

3771

(21494815) CD4 cells/100 lymphocytes in Specimen

3.40

7.52

2.0

2.3

30.68

42.55

2.78

(3024522) Salmonella sp identified in Specimen by Organism specific culture

220

2.34

7.40

1.8

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

214

2.36

7.38

1.8

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

13.39

7.38

1.4

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

5.97

7.37

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

1992

21130

0.77

7.34

53.8

21.1

123.11

136.05

g/l

195.81

1947

20657

(3035941) MCH [Entitic mass]

1992

21128

0.77

7.31

53.2

20.9

30.30

30.52

4.56

1947

20652

(3026361) Erythrocytes [#/volume] in Blood

1992

21128

0.77

7.31

53.4

21.0

4.13

4.48

e12/l

130.27

1927

20289

(3024731) MCV [Entitic volume]

1992

21126

0.77

7.29

53.3

20.9

91.47

91.66

0.84

1949

20648

(3010813) Leukocytes [#/volume] in Blood

1992

21126

0.77

7.29

53.4

21.0

7.25

6.87

e9/l

7.83

1929

20289

(21494434) Karyotype in Bone marrow

155

2.60

7.28

1.1

1.2

—

(3007461) Platelets [#/volume] in Blood

1992

21123

0.77

7.25

53.4

21.0

224.98

238.32

e9/l

9.46

1931

20379

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

506

3996

1.33

7.23

2.2

1.7

2.78

1.34

mg/l

6.08

421

3103

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

395

1.98

7.23

1.6

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

189

2778

0.66

7.19

1.2

12.27

16.11

u/ml

0.28

1031

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

262

2.20

7.14

1.9

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

262

2.20

7.14

1.9

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

269

2.18

7.11

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

1992

21110

0.78

7.10

54.1

21.1

36.82

40.11

84.47

1813

19264

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

218

2.32

7.09

1.8

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

134

2.71

7.09

1.9

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

145

905

1.64

7.08

2.0

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

675

5562

1.29

7.03

3.6

2.6

4032.88

6377.96

umol/l

0.70

595

4719

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

125

2.74

6.86

1.6

11.40

14.88

umol/l

2.77

113

(3009343) pH of Capillary blood

209

1432

1.50

6.80

3.9

3.6

7.44

7.41

1.29

165

(21494755) Public health laboratory ask at order entry panel

892

0.43

6.77

1.2

1.4

—

(3004775) Volume in Urine collected for unspecified duration

205

2.32

6.68

2.1

2.2

854.74

616.83

2.36

123

(40768800) Prostate Pathology biopsy report

127

2.70

6.67

1.3

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

127

2.70

6.67

1.4

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

380

1.95

6.60

1.5

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.89

6.60

1.6

3.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

113

674

1.71

6.58

2.2

2.8

—

(3012441) Differential panel - Pleural fluid

207

2.29

6.54

1.7

1.5

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

210

1452

1.48

6.54

3.9

3.6

4.93

5.17

kpa

4.16

199

1358

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

108

642

1.71

6.38

2.3

2.1

165.19

89.90

ug/min

0.68

378

(3043409) Potassium [Moles/volume] in Arterial blood

117

711

1.68

6.37

4.3

4.1

3.93

3.95

mmol/l

0.13

117

702

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1031

0.48

6.35

1.6

1.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

858

9900

0.80

6.33

4.3

3.9

2.16

2.15

ug/l

0.02

721

8804

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

6.55

6.33

1.7

3.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

296

2.05

6.32

1.7

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

198

2.29

6.29

3.1

3.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1269

14052

0.81

6.29

3.9

3.6

14.96

15.04

pmol/l

0.50

1109

12503

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

9.27

6.28

1.0

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.35

6.27

3.7

2.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

115

2.72

6.18

1.6

1.3

—

(3000012) Reticulocyte production index

292

2.04

6.17

1.8

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

266

2.09

6.11

1.7

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

8.60

6.05

8.7

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

585

4821

1.27

5.96

4.4

3.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

229

2.16

5.95

1.6

1.3

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

131

835

1.60

5.93

1.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

142

923

1.57

5.91

1.4

1.5

3.74

21.17

u/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

118

2.65

5.90

1.6

1.3

—

(3037121) Protein [Mass/volume] in Urine

112

688

1.66

5.88

3.7

2.6

0.25

0.29

g/l

0.26

238

(3000093) Morphology [Interpretation] in Blood Narrative

198

2.24

5.86

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

197

1385

1.46

5.66

4.0

3.5

1.99

1.88

mmol/l

0.12

133

993

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

243

2.08

5.52

1.7

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

192

2.21

5.41

1.6

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

192

2.21

5.41

1.6

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

16.05

5.41

5.3

3.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

2.83

5.40

1.8

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.87

5.35

1.8

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.87

5.35

1.8

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

2.79

5.30

1.8

1.3

—

(3021374) Sirolimus [Mass/volume] in Blood

+∞

5.21

15.6

0.0

8.88

—

ug/l

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

+∞

5.21

1.0

0.0

16.80

—

umol/l

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

7.36

5.14

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

158

2.30

5.12

1.9

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

172

2.23

5.04

1.9

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

852

7435

1.21

5.02

4.1

3.8

13.17

8.35

mg/mmol

1.97

565

4770

(3035350) Ketones [Presence] in Urine by Test strip

1068

9524

1.20

5.02

4.4

3.7

0.00

0.01

estimate

0.11

259

1735

(3019225) pH of Specimen

270

2052

1.35

4.95

4.8

3.7

—

(3024928) Oxygen saturation in Venous blood

465

1.72

4.91

2.7

3.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

488

1.70

4.90

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

488

1.70

4.90

1.5

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

3.00

4.82

1.3

19.08

32.47

u/l

1.02

(3009214) Lutropin [Units/volume] in Serum or Plasma

280

1.91

4.69

1.3

1.4

9.46

7.89

u/l

0.56

225

(3009261) Glucose [Presence] in Urine by Test strip

1071

9611

1.19

4.57

4.4

3.7

0.00

0.01

estimate

1.08

222

1509

(3049717) Cytology report of Urine Cyto stain

111

726

1.55

4.57

2.6

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

214

1589

1.38

4.56

3.2

3.8

84.45

97.39

ng/l

1.97

193

1327

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

875

7716

1.20

4.53

2.7

2.2

74.47

78.51

nmol/l

3.54

802

6693

(3021601) Nitrite [Presence] in Urine by Test strip

1056

9478

1.19

4.47

5.7

5.0

0.00

estimate

-0.00

237

1581

(40757494) Bilirubin.total [Moles/volume] in Blood

111

2.45

4.46

2.0

1.8

128.78

20.46

umol/l

—

(3029937) Albumin [Presence] in Urine by Test strip

617

5270

1.22

4.43

5.0

4.1

0.00

estimate

0.50

210

1510

(1002224) Polysomnography panel

556

0.43

4.42

1.0

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

239

1819

1.34

4.36

2.7

2.2

225.92

176.51

ug/g

0.77

200

1440

(3033705) Calcium.ionized [Moles/volume] in Venous blood

296

1.84

4.30

2.6

2.2

—

(3016750) Collection duration of Urine

133

2.27

4.22

2.2

1.9

504.35

484.19

min

0.64

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

104

684

1.54

4.20

2.6

1.5

34.06

35.22

mg/l

0.16

554

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

666

0.49

4.20

1.4

1.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

104

685

1.54

4.18

2.6

1.5

50.83

49.49

mg/l

0.10

556

(3017732) Neutrophils [#/volume] in Blood

169

1225

1.41

4.18

4.1

3.2

6.63

5.75

e9/l

0.21

138

894

(3009508) Creatinine [Moles/volume] in Urine

810

7138

1.19

4.15

3.5

3.1

7.12

7.49

mmol/l

1.63

655

5940

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

109

2.40

4.14

1.7

1.3

—

(1761482) Bacteria [#/volume] in Urine by Culture

608

1.57

4.10

4.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

552

0.45

4.09

1.2

1.1

—

(3021901) Oxygen saturation in Capillary blood

436

1.67

4.09

2.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

203

1548

1.34

3.69

1.9

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

282

2251

1.28

3.67

3.3

3.1

199.60

248.63

ng/l

1.77

263

2074

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

667

1.50

3.63

2.6

1.5

3.57

3.32

ratio

—

(3039443) Prostate specific Ag panel - Serum or Plasma

429

0.42

3.62

1.2

1.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

826

7367

1.18

3.59

4.8

4.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

138

2.11

3.49

1.9

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

138

2.11

3.49

1.9

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

138

2.11

3.49

1.9

1.2

—

(3042631) Mycobacterium sp identified in Specimen

258

1.80

3.47

2.2

2.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

505

1.56

3.44

2.6

1.5

—

(3012516) Albumin [Mass/volume] in Urine

786

7003

1.17

3.43

3.5

3.2

429.26

206.98

mg/l

0.73

534

4567

(3013512) EKG study

714

6313

1.18

3.42

4.5

4.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

419

1.61

3.42

1.3

0.69

0.83

nmol/l

1.01

343

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

414

3490

1.22

3.34

1.2

2.33

1.94

u/ml

0.20

888

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

233

1.82

3.30

1.2

170.43

185.79

miu/ml

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.30

3.26

7.0

4.5

61.82

73.38

mg/l

0.34

(3009871) Measles virus Ab [Titer] in Serum

3.03

3.25

1.8

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.51

3.21

1.7

1.4

52.56

118.67

umol/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

6.38

3.18

1.1

3.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1964

20421

0.85

3.14

30.3

9.3

41.23

25.76

u/l

73.95

1927

19419

(3015736) pH of Urine

848

7645

1.16

3.14

4.0

3.5

5.74

5.80

0.18

336

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.81

3.08

1.1

1.2

21.83

6.10

ug/l

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

103

727

1.43

3.03

1.7

1.8

46.91

38.28

u/l

2.73

597

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.90

3.02

1.2

—

(3022313) Gas panel - Capillary blood

140

1044

1.36

3.00

4.5

3.8

—

(3037756) Immunofixation for Serum or Plasma

411

1.57

2.97

1.3

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

177

0.28

2.96

1.2

1.1

—

62.73

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

614

1.47

2.96

2.1

1.4

0.00

g/l

-0.00

550

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

604

1.46

2.82

2.2

1.4

0.00

g/l

-0.00

548

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

175

0.28

2.81

1.2

1.1

—

87.00

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

278

1.67

2.74

2.2

23.92

21.77

mg/l

0.09

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.72

2.71

2.8

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.72

2.71

2.8

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.72

2.71

2.8

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

655

1.42

2.63

2.1

1.4

0.07

0.04

g/l

0.23

590

(3035880) pH of Pleural fluid

106

2.08

2.63

1.1

1.3

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

113

2.04

2.61

1.2

1.3

1.17

1.09

nmol/l

0.13

(3003338) MCHC [Mass/volume]

1491

15718

0.88

2.59

46.7

19.0

331.18

332.41

g/l

5.45

1475

15532

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

101

734

1.39

2.57

2.0

1.4

0.58

0.45

g/l

0.20

618

(3019309) Folate [Moles/volume] in Red Blood Cells

537

4748

1.16

2.52

1.9

1.8

1192.71

1165.48

nmol/l

0.26

419

3527

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1717

17924

0.88

2.49

36.2

13.4

77.33

73.93

ml/min/173m2

8.29

1531

14452

(3001019) Free T4 and TSH panel - Serum or Plasma

444

0.54

2.46

1.3

1.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

110

819

1.36

2.43

2.0

1.4

11.81

10.41

g/l

1.70

700

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.29

2.41

2.5

1.6

0.21

e9/l

0.01

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

160

0.31

2.41

1.2

1.1

—

5.40

—

(3004451) EKG impression Narrative

110

2.01

2.40

1.1

1.3

—

(3008295) Osmolality of Serum or Plasma

182

1.77

2.39

1.1

1.4

282.08

276.12

mosm/kgh2o

0.60

134

(3026389) Candida sp identified in Specimen by Organism specific culture

212

1.71

2.39

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

278

2333

1.21

2.38

2.4

5.82

7.65

ug/l

0.96

242

2010

(3014148) Varicella zoster virus Ab [Titer] in Serum

139

1.88

2.36

1.0

1.1

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1981

20465

0.87

2.34

42.9

17.8

3.99

4.01

mmol/l

1.94

1937

19821

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.26

2.34

2.4

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.26

2.34

2.4

1.2

—

(3011648) Oxygen content in Venous blood

154

1.83

2.34

3.1

1.9

11.54

10.60

0.61

154

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

768

0.66

2.33

1.2

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

542

4825

1.15

2.31

1.8

1.7

48993740.23

36589524.01

pmol/l

0.12

447

3911

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

115

871

1.33

2.29

2.1

1.4

7.53

g/l

0.01

100

756

(3000330) Specific gravity of Urine by Test strip

144

1128

1.29

2.26

4.0

3.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

988

9161

1.12

2.25

2.1

88.76

93.26

pmol/l

2.27

511

4806

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

116

883

1.33

2.24

4.9

4.0

24.55

24.75

mmol/l

0.23

109

799

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.20

2.21

2.5

1.5

411.38

392.51

e6/l

0.07

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

868

1.33

2.21

2.1

1.4

4.16

3.76

g/l

2.18

100

755

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

704

1.36

2.20

2.1

1.4

35.42

37.30

g/l

2.31

590

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

257

1.60

2.18

1.9

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

756

0.67

2.18

1.1

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

114

871

1.32

2.16

2.1

1.4

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

108

820

1.33

2.14

2.1

1.4

3.03

3.00

g/l

0.11

707

(3019550) Sodium [Moles/volume] in Serum or Plasma

1980

20420

0.88

2.13

42.8

17.6

138.02

139.75

mmol/l

104.62

1939

19809

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.37

2.12

1.3

—

(40768446) Kidney Pathology biopsy report

2.26

2.07

1.1

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

2.33

2.04

1.8

1.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.01

2.04

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.01

2.04

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.51

2.01

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

141

1121

1.27

2.01

2.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

511

1.40

1.98

2.3

2.2

119.39

131.64

g/l

3.34

383

(21494890) Protein electrophoresis panel - 24 hour Urine

195

1.65

1.93

1.6

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.45

1.93

1.2

1.3

—

(4200892) Spirometry reversibility

114

1447

0.78

1.88

1.3

1.4

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.19

1.88

1.9

1.5

—

(3016244) Insulin [Units/volume] in Serum or Plasma

2.09

1.86

2.4

3.4

26.28

33.78

mu/l

0.21

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

227

2673

0.84

1.86

4.4

4.9

32.84

33.10

0.12

159

1771

(3020393) Adenovirus Ag [Presence] in Stool

3.53

1.83

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

248

0.48

1.80

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.58

1.80

3.2

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

131

1.76

1.77

1.3

1.4

16.39

14.28

u/l

0.48

125

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

271

0.51

1.74

1.1

—

(3020650) Glucose [Presence] in Urine

2.50

1.74

1.1

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

191

0.47

1.72

1.0

1.1

—

1.64

—

(3005322) IgE [Units/volume] in Serum or Plasma

958

0.74

1.71

1.2

1.3

320.90

258.98

u/ml

0.30

884

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.92

1.70

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.92

1.70

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.16

1.66

1.0

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

2.59

1.66

1.3

1.4

39.54

68.37

u/l

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

520

4721

1.13

1.65

3.9

3.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

105

828

1.28

1.64

2.0

2.3

516.00

732.26

ug/l

0.25

100

784

(3028717) Thiamine [Mass/volume] in Blood

3.58

1.61

1.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.84

1.61

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.84

1.61

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

113

1403

0.80

1.59

1.5

1.4

—

(44786800) Granulocytes/100 leukocytes in Body fluid

3.00

1.58

1.0

1.3

42.83

18.07

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

3.00

1.58

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

172

0.46

1.58

1.1

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.28

1.55

1.1

1.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.98

1.54

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.60

1.51

2.0

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

291

1.45

1.50

1.1

365.82

83.94

iu/ml

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1966

19133

1.11

1.50

38.0

14.5

36.37

25.80

mg/l

31.52

1898

15123

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

2.07

1.49

1.0

1.1

1451.17

1553.97

miu/ml

0.13

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.07

1.49

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

2.23

1.46

1.1

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.37

1.45

1.0

1.2

69.33

94.25

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.13

1.44

1.0

1.2

—

(3019977) pH of Arterial blood

125

1.69

1.43

2.4

2.3

7.43

7.42

0.03

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.73

1.43

1.0

1.2

—

(4034850) Laboratory test

761

0.74

1.43

18.5

10.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

101

811

1.26

1.40

3.2

2.9

4.13

4.44

pmol/l

2.58

687

(3034426) Prothrombin time (PT)

2.08

1.38

1.5

1.3

—

(40765096) Chromosome analysis panel by Banding

2.61

1.36

1.3

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

879

9307

0.92

1.33

2.6

2.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.97

1.32

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

233

0.56

1.32

1.2

1.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

533

1.30

1.31

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

553

0.72

1.28

1.2

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

210

1.48

1.27

1.4

33.16

31.15

iu/l

0.10

176

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.00

1.27

1.3

1.4

15.32

9.40

ug/l

0.97

(3008898) HLA-B27 [Presence]

424

0.68

1.26

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

530

1.29

1.23

1.2

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.63

1.21

1.0

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

322

1.37

1.21

4.4

3.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

650

0.75

1.21

1.4

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.17

1.21

1.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

215

1884

1.15

1.21

1.3

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1201

0.82

1.19

1.2

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

571

5305

1.10

1.19

1.8

1.6

18.05

19.77

nmol/l

2.55

516

4448

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

165

1.52

1.17

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

283

1.38

1.14

1.5

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

152

0.52

1.14

1.0

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

1.14

0.0

2.0

—

45.23

—

(42529406) Shigella sp [Presence] in Stool by Culture

538

1.27

1.12

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

135

1.56

1.11

2.3

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.26

1.10

1.3

1.1

—

(40761511) CBC panel - Blood by Automated count

1926

19680

0.92

1.09

34.5

14.2

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

181

0.55

1.08

1.0

1.1

—

23.70

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

202

1.44

1.07

1.3

1.4

—

nmol/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

435

1.29

1.07

1.3

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

204

0.59

1.05

1.2

1.7

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1.79

1.04

1.2

1.4

0.10

0.20

nmol/l

—

(3040151) Glucose [Moles/volume] in Capillary blood

289

1.35

1.03

8.3

9.6

8.50

7.68

mmol/l

0.61

240

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

575

0.76

1.02

1.2

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

574

0.76

1.01

1.3

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

132

0.53

0.98

1.4

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

693

1.22

0.98

1.3

1.2

—

(3011288) Drugs identified in Urine by Screen method

135

0.52

0.98

4.4

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

224

1.39

0.96

2.0

1.85

1.66

g/24h

0.09

100

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

648

6858

0.93

0.94

2.1

2.2

177.19

233.90

u/l

1.79

608

6374

(3000475) Leukocytes [#/volume] in Synovial fluid

556

0.77

0.94

1.7

1.6

14553.97

14253.90

e6/l

0.02

410

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

125

1.52

0.94

1.1

—

(3044889) 12 lead EKG panel

1442

13998

1.07

0.91

4.8

4.2

—

(3028433) Virus identified in Specimen by Culture

1.79

0.87

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.82

0.85

1.0

1.1

—

(3028300) Cannabinoids [Presence] in Urine

216

0.65

0.85

1.8

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

112

1.52

0.84

1.6

1.8

—

(3027008) Opiates [Presence] in Urine

215

0.65

0.84

1.8

1.3

—

(3048879) Bone marrow aspiration report

1.78

0.84

1.3

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

113

0.53

0.83

1.0

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

163

1.41

0.82

2.4

2.3

—

(3000764) Benzodiazepines [Presence] in Urine

212

0.66

0.80

1.8

1.3

—

(3027944) Amphetamines [Presence] in Urine

212

0.66

0.80

1.8

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.79

0.0

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

1.67

0.78

1.0

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.77

0.0

1.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

326

0.73

0.77

1.2

—

54.03

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

107

1.50

0.76

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.09

0.74

1.4

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

460

1.22

0.73

1.6

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

202

1.34

0.72

1.2

1.3

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

106

0.57

0.72

1.0

1.1

—

0.60

—

(40757373) Influenza virus identified in Isolate

1.58

0.71

1.0

1.4

—

(3017569) Oxygen content in Arterial blood

126

1.43

0.70

2.4

1.8

—

(3044927) Protein electrophoresis panel - Urine

286

0.73

0.70

1.3

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.71

0.70

1.0

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

195

1.34

0.69

1.7

2.2

1.83

1.62

u/field

0.17

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

397

0.78

0.68

1.2

1.3

2.00

27.56

e6/l

1.07

320

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

397

0.78

0.68

1.3

19.36

826.86

e6/l

1.62

334

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

240

1.30

0.67

1.3

1.2

1.53

3.01

u/ml

0.84

(3006270) Folate [Moles/volume] in Blood

205

1.32

0.67

1.2

336.20

343.99

nmol/l

0.06

166

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.55

0.67

1.0

1.1

—

(3023419) Bacteria identified in Sputum by Culture

357

1.24

0.66

1.7

2.4

—

(44813793) Dust mix specific IgE antibody measurement

0.53

0.66

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.79

0.66

1.0

1.3

—

(3016879) Cocaine [Presence] in Urine

200

0.70

0.63

1.8

1.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

479

1.19

0.62

1.6

1.5

0.23

g/l

0.18

455

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

267

2869

0.92

0.61

14.3

7.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

423

0.80

0.61

1.2

4.21

3.99

mmol/l

0.44

393

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.60

0.0

1.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.60

0.0

4.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.00

0.59

0.0

1.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.58

0.0

1.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

228

1.27

0.58

1.2

1.4

1.15

0.66

nmol/l

0.45

219

(3021788) Differential panel - Synovial fluid

398

0.80

0.58

1.3

1.4

—

(3036180) Methadone [Presence] in Urine

1.72

0.57

1.5

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

115

1.39

0.56

2.1

1.9

15.94

17.37

nmol/l

—

(3014271) Vancomycin [Susceptibility]

150

1.34

0.55

2.3

3.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

186

1.29

0.54

1.1

—

(3024263) Appearance of Synovial fluid

135

0.67

0.51

1.1

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

356

0.81

0.49

1.1

1.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1465

14380

1.04

0.49

4.9

4.1

21.78

12.91

mm/h

43.83

1339

13171

(3017446) Testosterone [Moles/volume] in Serum or Plasma

140

1281

1.10

0.48

2.1

12.15

14.69

nmol/l

2.24

117

1114

(3022621) pH of Urine by Test strip

150

1379

1.09

0.47

3.4

3.1

—

(4146454) Self-monitoring of blood glucose

281

1.21

0.47

2.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

621

0.87

0.45

1.3

1.4

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.40

0.45

2.7

1.9

0.51

1.54

ug/l

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

264

0.79

0.44

1.3

1.4

51.92

64.70

0.59

171

(3045414) Leukocytes [Presence] in Urine

820

1.11

0.43

2.1

1.9

—

(3014891) Appearance of Pleural fluid

1.61

0.43

1.8

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

273

0.80

0.42

1.5

1.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.66

0.42

1.0

1.4

1.35

1.55

g/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.56

0.42

1.2

1.4

—

70.40

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.64

0.42

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.52

0.41

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.36

0.41

9.9

7.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.00

0.40

0.0

1.5

—

(3019174) dRVVT (LA screen)

0.00

0.40

0.0

1.2

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.40

0.0

1.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.00

0.39

0.0

1.2

—

330.12

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

204

0.78

0.39

1.4

18.56

24.83

—

135

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

137

0.73

0.39

1.6

1.5

145.41

169.62

pmol/l

—

137

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.34

0.38

2.0

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.34

0.38

2.0

2.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.34

0.38

8.9

7.1

—

(36660697) Celiac disease serology panel - Serum

138

1281

1.08

0.38

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.33

0.37

1.7

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

234

1.20

0.37

1.4

1.2

2.18

6.66

u/ml

2.62

114

(40761535) Cells panel - Urine sediment

200

1884

1.07

0.37

3.6

3.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.31

0.37

1.1

1.2

—

0.06

g/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

208

1.20

0.35

1.2

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.31

0.33

1.0

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.31

0.33

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.69

0.33

1.2

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.28

0.32

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.31

0.31

1.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.32

0.30

1.3

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.71

0.30

1.4

2.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

218

0.82

0.30

1.4

1.2

17099.15

151295.40

e6/l

1.76

151

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

129

1.24

0.30

1.0

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

129

1.24

0.30

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

129

1.24

0.30

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.33

0.30

1.3

136.50

174.41

mmol/24h

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

118

0.76

0.27

6.9

3.9

14.28

13.27

—

118

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

319

1.13

0.26

1.4

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

160

0.81

0.26

1.8

1.3

—

(3025130) Human papilloma virus identified in Specimen

0.67

0.25

1.8

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

132

1.21

0.25

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

132

1.21

0.25

1.0

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

132

1.21

0.25

1.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

463

4506

1.03

0.25

5.0

4.1

1.02

kg/l

0.10

691

(3002523) Influenza virus A Ag [Presence] in Specimen

148

0.81

0.24

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

180

0.83

0.24

1.1

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.72

0.24

1.5

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

147

0.82

0.23

18.2

11.9

—

(3044941) Cell count panel - Synovial fluid

358

0.89

0.22

1.3

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.75

0.22

1.0

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.21

0.0

2.3

—

4.24

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.21

0.0

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.7

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

42.88

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.24

0.21

1.0

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

198

0.86

0.20

1.1

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.20

0.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.25

0.20

8.0

7.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

851

0.94

0.20

1.1

1.2

172.45

119.24

iu/ml

0.26

313

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

186

0.86

0.19

1.0

1.1

0.32

1.62

u/ml

—

(3002385) Erythrocyte distribution width [Ratio]

1591

16035

0.98

0.19

46.2

16.6

15.62

15.34

1.69

1572

15642

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

164

0.85

0.18

1.0

1.4

—

66.67

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

164

0.85

0.18

1.0

1.1

3.66

5.82

u/ml

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1.17

0.17

1.3

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

174

0.86

0.17

1.0

1.4

—

203.91

—

(3005570) Glucose [Moles/volume] in Urine

225

0.89

0.16

1.4

1.9

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

162

0.86

0.16

1.0

1.1

0.03

1.83

u/ml

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

349

0.92

0.15

1.5

1.8

2.16

4.61

iu/l

—

108

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.77

0.15

1.3

2.1

10.48

115.77

ug/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

391

1.08

0.14

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

132

1.14

0.13

2.5

2.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

521

1.06

0.12

1.4

1.6

1.43

6.11

iu/ml

0.40

115

(3006462) Nitrate [Presence] in Urine

104

1.15

0.12

2.6

3.7

—

(3006653) Thiamine [Moles/volume] in Blood

104

1.15

0.12

1.1

1.2

112.17

146.98

nmol/l

1.87

104

(3038177) Helicobacter pylori Ab [Presence] in Serum

229

1.09

0.12

1.2

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

497

0.94

0.11

2.9

3.8

33.32

29.27

mg/l

0.39

334

(3003740) Influenza virus B Ag [Presence] in Specimen

147

0.88

0.11

1.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

221

1.09

0.11

3.8

—

(3023410) Appearance of Cerebral spinal fluid

163

1.11

0.10

1.5

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

1.11

0.09

8.8

5.8

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.09

0.09

1.0

1.1

—

35.40

—

(3023420) DNA double strand Ab [Units/volume] in Serum

165

0.91

0.08

1.5

1.3

—

26.13

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

512

0.96

0.08

1.5

1.8

55.02

42.89

nmol/l

2.06

487

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

175

1.09

0.08

1.2

104.58

94.71

1.11

165

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.81

0.08

1.0

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

399

0.95

0.08

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.86

0.07

1.2

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.84

0.07

1.0

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

521

1.04

0.07

2.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

206

1.07

0.07

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

463

0.97

0.04

1.9

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

220

1.05

0.03

1.3

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

219

0.96

0.03

1.1

—

13.93

—

(3016018) Differential panel - Cerebral spinal fluid

168

0.95

0.02

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

208

0.96

0.02

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

143

1.05

0.01

2.1

1.9

73.13

93.46

umol/l

2.07

143

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

343

1.02

0.01

1.1

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

447

0.98

0.01

2.2

1.9

12.54

12.03

mg/l

0.11

406

(3032773) Endomysium IgG Ab [Titer] in Serum

134

1.05

0.00

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

224

1.03

0.00

4.4

2.9

41.58

29.60

mg/l

0.18

171

(3039162) Centromere protein B Ab [Units/volume] in Serum

201

0.99

0.00

1.0

1.2

—

56.29

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

106

1.04

0.00

4.3

3.8

—

(3017704) Immunofixation for Urine

124

0.97

0.00

1.0

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

144

0.97

0.00

1.0

1.1

3.45

2.20

u/ml

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

118

1.02

0.00

3.2

2.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

614

0.99

0.00

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

588

1.00

0.00

2.7

3.1

0.80

0.85

nmol/l

0.45

440

(3000492) Spirometry study

161

1613

1.00

0.00

1.4

1.5

—

(40768443) Skin Pathology biopsy report

733

1.00

0.00

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

1.03

0.00

1.6

1.4

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.0

1.2

—

7.88

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.00

0.00

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.1

—

1.30

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.94

-0.00

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.6

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.02

-0.00

1.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

5.40

—

(3047189) Immunofixation for 24 hour Urine

1.01

-0.00

1.6

1.1

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

7.82

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

-0.00

0.0

1.0

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.01

-0.00

1.0

1.2

—

13.20

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.93

-0.00

1.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

-0.00

0.0

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.85

-0.00

1.2

1.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

3.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.01

-0.00

1.1

1.2

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.97

-0.00

1.6

2.4

1283.29

972.86

u/ml

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.88

-0.00

1.8

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.0

—

3.74

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.50

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_BILIARY_GALLBLADDER_WIDE – Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

GWS hits: 3

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo (C3_BILIARY_GALLBLADDER_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints